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Spinal cord injury is a devastating source of suffering in the spectrum of human 
pathophysiology; advancement for clinical therapy in this area has been stagnant in 
comparison to modern medical development. Current treatments are palliative, and 
functional recovery is minimal. During the first two weeks after injury, dense glial scar 
forms that is impenetrable by regenerating axons. Intervention is imperative to minimize 
scar formation and provide a supportive environment for axonal regeneration. 
Oligodendrocytes are critical to maintain the health of growing axons during 
development and after injury. Obtaining these cells through differentiation of neural 
progenitor cells (NPCs) is a viable option, but current clinical trials involving stem cells 
are plagued by poor cell survival and undirected differentiation. Research indicates that 
local extracellular matrix (ECM) is vital to progenitor differentiation and tissue 
regeneration. During development, spinal cord ECM is comprised of high concentrations 
of laminin and hyaluronic acid (HA), which provide essential cues to direct NPC 
migration and differentiation.  
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The purpose of this research is to create a biomaterial optimized to direct NPC 
differentiation to oligodendrocytes. Natural biomaterials were optimized from distinct 
combinations of collagen I, HA, and laminin I to model the native ECM signals found 
during oligodendrocyte maturation. Four material combinations (collagen, collagen-HA-
laminin, collagen-HA, and collagen-laminin) were fabricated into injectable hydrogels to 
mimic the range of compressive and shear mechanical properties present in neonatal 
central nervous system (CNS) tissue. Differentiation was assessed by culturing rodent 
fetal NPCs in these materials without specific soluble factors to direct cellular behavior. 
The three-component hydrogel performed optimally and achieved a 66% oligodendrocyte 
differentiation rate compared to approximately 15% in the collagen alone hydrogel. 
An in vivo study was then conducted using a rat contusion model of spinal cord injury 
with intervention using the injectable, three-component hydrogel seeded with rat NPCs. 
Functional recovery was assessed using six behavioral tests. Significant recovery was 
observed using two behavioral tests six weeks post-treatment. Lesion size was measured 
and correlated well with behavioral outcomes. The data obtained in this research indicate 
that a multi-component hydrogel mimicking native, developmental CNS tissue may 
address problems associated with current clinical practice. 
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Chapter 1: Introduction and Background12  
 Spinal cord injury (SCI) is a devastating source of suffering in the spectrum of 
human pathophysiology. Notably, outcome improvement has remained stagnant in 
comparison to other clinical advancement throughout the history of modern medicine; 
currently treatments are palliative and functional recovery is minimal [1]. During the first 
2 weeks after injury, a dense glial scar forms that is impenetrable by regenerating axons. 
Approaches to minimize scar formation and provide a supportive environment for axonal 
regeneration are imperative to improving outcomes after injury. Oligodendrocytes have 
been shown to be critical in maintaining the health of growing axons during development 
and regeneration and are important in retaining axonal function locally after injury [2, 3]. 
Obtaining these cells through differentiation of neural progenitor cells (NPCs) is feasible, 
but current clinical trials involving stem cell transplantation are plagued by poor cell 
survival and undirected differentiation in vivo [4]. Research indicates that local 
extracellular matrix (ECM) is critical to direct cell differentiation during development 
and healing. During development of the mammalian nervous system, the spinal cord 
ECM is comprised of high concentrations of laminin and hyaluronic acid (HA) [5, 6]. 
Laminin is a major component of the basement membrane of blood vessels in the mature 
tissue [7] and has been reported as an adhesive component associated with glial cell 
migration [8-11]. Conversely, HA is non-adhesive to mature cells but presents active 
                                                
1 Parts of this chapter follow closely from a prior publication, of which I am a co-author, [27].  Dr. Khaing 
and Dr. Thomas each contributed to sections of the paper as well.  Dr. Schmidt acted as the mentor and 
directed us in the writing of this review article. 
2 Parts of this chapter follow closely from a prior publication, of which I am first author, [57]. Dr. Schmidt 
and Dr. Schallert acted as my mentors and directed me in writing this review article. 
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migratory cues to progenitor cells [5, 12, 13]. HA has been applied to spinal cord injury 
to reduce scar formation and inflammatory response [14, 15]. These components provide 
critical cues to neural progenitor cells during development to direct migration and 
differentiation. 
 Though researchers have attempted to treat spinal cord injury with NPC 
transplantation, few studies have produced robust results indicating successful 
differentiation of the transplanted cells and many transplanted cell populations exhibit 
low cell survival. Merging the fields of biomedical engineering and neuroscience to 
approach this problem may be the most successful option. The purpose of this research is 
to develop a biomaterial optimized to direct NPC differentiation to oligodendrocytes 
based on cues present during development.  
STATISTICS OF CLINICAL SPINAL CORD INJURY 
Over one million people suffer from paralysis due to spinal cord injury [4]. This is 
an injury most commonly sustained by healthy individuals between the ages of 19 and 
29. Therefore, many patients endure decades with a severely decreased quality of life 
following their injury. The most common causes of spinal cord injury in the United States 
are work-related and motor vehicle accidents, however over 16% of these injuries are 
sustained during sporting or recreational outings [1, 4]. This injured population 
introduces novel issues in that they derive from an active and healthy subpopulation, 
rather than the elderly or other groups that are chronically prone to injury and require 
frequent medical intervention. Furthermore, most spinal cord injury patients have an 
opportunity to receive treatment at an age where the likelihood of healing and 
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regeneration is relatively high. These young and otherwise healthy patients are a 
promising population for various treatment strategies. 
With many sufferers sustaining their injury at a young age, the lifetime cost of the 
spinal cord injury can be very high. In the first year, treatment costs can range from 
$300,000 to over $1,000,000, depending on the level of the injury. Each following year, 
costs range from $40,000 to over $150,000 [1, 4, 16]. These numbers suggest that the 
lifelong treatment for one patient can cost more than $3,000,000. Patients pay much of 
this price out of pocket. However, government and private health benefits also assume 
significant monetary burden for these patients. New treatments for spinal cord injury 
could increase patients’ quality of life and reduce governmental healthcare spending by 
400 billion dollars in future costs [1, 4, 16]. 
 Spinal cord injury patients experience different levels of paralysis depending on 
their injury level. If the injury is contained below the first thoracic vertebra, the patient 
can experience a range of effects, including complete or partial paralysis of the legs and 
complete paralysis of abdominal muscles up to the nipple level, resulting in an inability 
to sit up straight without assistance. A person with an injury at or above the first thoracic 
vertebra will suffer quadriplegia or tetraplegia, meaning full or partial paralysis of all four 
limbs. In addition, patients with this level of injury can experience difficulty breathing, 
impaired coughing and clearing of the chest, as well as instability while sitting [4, 17].  
Paralysis of the musculoskeletal system is the most readily observable pathology 
associated with spinal cord injury. However, decreases in sensitivity of the sensory 
nervous system also occur. Decreasing sensitivity increasing a patient’s risk of disease or 
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injury by diminishing their responsiveness to potentially harmful. One example is “bed 
sores,” or necrotic tissue at locations where body weight has been applied over a long 
period of time without sufficient movement or circulation [4, 17]. Prolonged pressure and 
resulting ischemia from immobility causes the skin and surrounding tissue to die and can 
lead to deep open wounds, increasing the risk of infection. Sensory and motor 
dysfunction can also affect an individual’s mental health. These patients must learn to 
depend on assistance to survive and may find the experience humiliating and degrading. 
People who have sustained spinal cord injuries can also suffer from bladder and 
bowel dysfunction. To manage these symptoms, people with a cervical or high thoracic 
injury often require catheters or attached urine bags and the execution of a daily bowel 
plan [4, 17-19]. If the injured person has a lower level injury, they are often able to 
perform many necessary tasks on their own after receiving instruction on how to perform 
the movements appropriately. In the first few weeks of learning, they must rely on 
assistance to tend to their bowel movements. Such invasive requirements forces these 
patients into a situation where they lack personal space and report feelings inherent to a 
compromised personal dignity [4, 17, 18]. Bladder and bowel issues are some of the least 
discussed side effects associated with spinal injuries, and people who have not directly 
dealt with paralysis often overlook these issues [4]. Additionally, many spinal cord 
injured people suffer sexual dysfunction in relation to sensation, as well as degradation or 
complete eradication of function in the sexual organs [4]. 
When the injury is at the 5th or 6th thoracic vertebra, the body experiences 
something called autonomic dysreflexia, also called hyperreflexia [4, 17, 20, 21]. This 
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condition can be life-threatening. This phenomenon results in the autonomic nervous 
system overreacting to issues that the spinal cord injured person cannot otherwise sense. 
For example, the body can respond to a full bladder by causing the person’s blood 
pressure to rise excessively, leading to a faster heartbeat, tingling around the face and 
neck, blotchy skin, a pounding headache, and even fever. This reaction can be fatal in 
some cases if treatment is not sufficient [17]. Furthermore, this condition can occur in 
situations that would otherwise not be adverse, such as a full bladder or a sub-lethal 
bacterial infection. This reaction can also occur during sexual activity or other 
pleasurable behaviors [17].  
When patients with spinal cord injury were surveyed to determine what features 
of their injury they would like treated, or which area of dysfunction they would like 
addressed first, they gave some unexpected answers. Quadriplegic patients requested that 
research focus on regaining bowel and bladder control, followed by sexual function. 
After these two choices, arm control trailed on the list as the next most important 
recovered ability, followed by a return to walking. Similarly, paraplegics also ranked 
bladder and bowel dysfunction above sexual dysfunction, followed by walking [4, 22].  
SPINAL CORD CELL TYPES 
To understand the downstream healing response after spinal cord injury, it is 
essential to first understand the native cell types of the central nervous system (CNS). 
The CNS has two categories of cell types: neurons and glia. Neurons are the signal-
conducting cells that respond to chemical and electrical stimuli to transmit information 
throughout the brain and spinal cord and communicate to the peripheral nervous system. 
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It is critical that these cells be protected from infection and damage, and neurons are 
frequently the focus of repair strategies for CNS disease or damage [23-25].  
Glial cells function to enhance the capabilities of the nervous system by 
interacting with the systemic environment and increasing the rate at which neurons can 
transmit signals. There are three types of glial cells: astrocytes, microglia, and 
oligodendrocytes. Astrocytes are heavily involved in the blood brain barrier and blood 
spinal cord barrier, with tight junctions formed between astrocytes and endothelial cells 
in blood vessels. Astrocytes shuttle nutrients and chemical signals from the circulating 
blood to neurons and CNS tissue [9, 10]. In normal physiological conditions, very few 
molecules can move from blood to the CNS tissue passively. This is an obstacle to 
delivering therapeutics to the CNS, but is important to maintain a thriving CNS 
environment. Additionally, this barrier prevents access by the systemic immune system. 
Endogenous CNS macrophages, termed microglia, are distributed throughout the CNS 
tissue and act to clean debris and damaged cells. These phagocytes are particularly 
important when cells of the CNS die, as they remove components in the extracellular 
fluid that can affect regenerative [9, 10, 26].  
Astrocytes also function to absorb excess chemical signals around synapses, thus 
providing maintenance of the neurotransmission mechanisms [10, 27]. These functions 
are important to maintain the healthy environment of the CNS, as well as to enhance the 
neurotransmitter signal by preventing dilute signal from remaining in the synapse area 
[10, 27]. After injury to the CNS, astrocytes recreate the blood spinal cord barrier by 
creating a glial scar to prevent invading cells and chemicals from entering the undamaged 
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tissue. However, glial scar also creates a barrier to axonal growth necessary for restoring 
function [10].  
The final glial cell type of the CNS are oligodendrocyte, which act as the 
myelinating cells to increase electrical conduction speed of signals along axons. By 
wrapping the axons in myelin, oligodendrocytes enhance signal conduction to enable 
nearly immediate responses to sensory input and fast motor movement initiation [25, 28]. 
Oligodendrocytes also provide myelin associated protein signals that prevent axonal 
growth. Although beneficial in normal physiology to prevent aberrant sprouting, these 
inhibitory proteins are released into the environment when oligodendrocytes die, 
preventing axonal growth [29]. Endogenous and invading macrophages can assist in 
clearing the inhibitory myelin signals, but signals frequently persist after injury, 
contributing to axonal dieback [10, 26]. Oligodendrocytes and oligodendrocyte 
progenitor cells can respond to these signals and uptake myelin-associated molecules to 
assists in clearing the injury area [29]. 
Oligodendrocytes mature during the neonatal period of development [30]. During 
this time, the extracellular matrix is comprised of high concentrations of hyaluronic acid 
(HA), laminin I, and collagen IV, among other components [7, 8, 31, 32]. These 
molecules have been associated with oligodendrocyte progenitor cell migration [31, 32]. 
Hyaluronic acid has been implicated as a glycosaminoglycan that prevents the maturation 
of oligodendrocytes to a myelinating phenotype [33], however, it is supportive of NPC 
migration and proliferation. Hyaluronic acid concentration decreases during neonatal 
development, this decrease is followed by oligodendrocyte maturation [5, 12]. The 
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transition of ECM component concentrations during development provides timed cues to 
cells to enhance differentiation and cellular interaction. Notably, this component of the 
extracellular matrix has a decreased concentration in mature tissue correlating with the 
maturation of the axonal myelination in the spinal cord [34, 35]. Such findings indicate 
the importance of extracellular matrix signals in directing differentiation and maturation 
during development. 
SPINAL CORD INJURY 
A significant part of this section follows closely with a previously published 
manuscript with the same author [27].  
Cells respond to signals at all stages of development, the lack of pro-regenerative 
cues after SCI may contribute to the failure of spinal cord regeneration.  
After spinal cord injury, the blood spinal cord barrier is damaged causing 
infiltration of immune cells, fibroblasts, blood, and other external factors and cells to the 
CNS tissue [26]. These invading cells can cause cell death, axonal dieback, and damage 
to healthy tissue near the lesion. The astrocytic scar assists in preventing this passage of 
invading signals into the CNS. To create a viable barrier, the astrocytic scar forms around 
a fluid filled cavity, sealing the healthy CNS tissue from the exogenous factors (see Fig. 
1.1).  
Primary axonal death occurs acutely after injury in response to the trauma. During 
cavity formation, axons retract, or dieback in response to exogenous and endogenous 
signals. This dieback increases the cavity size and decreases the possibility for 
regeneration [10, 26, 36].  
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Astrocytes and oligodendrocyte progenitor cells create a scar to prevent 
exogenous factors from entering healthy spinal cord tissue. Astrocytes within the scar are 
considered reactive and are identified by hypertrophy, process extension, and increased 
glial fibrillary acidic protein (GFAP), vimentin, and nestin expression [37]. Hypertrophic 
oligodendrocyte progenitor cells increase their production of NG2 and localize to the scar 
as well. If the membrane around the CNS tissue known as the dura is broken, invading 
meningeal cells, infiltrating macrophages, and activated endogenous microglia contribute 
to the scar [38, 39]. Schwann cells from the local dorsal roots have been observed 
invading the injured area as well [40]. The presence of Schwann cells is associated with 
tissue sparing and remyelination [41, 42] but they are indicative of increased trauma with 








Figure 1.1: Spinal cord injury models. 
In healthy spinal cord tissue, myelinated fibers run along the white matter surrounding the 
gray matter. After a transection injury, reactive astrocytes form a scar around the created 
cavity and Schwann cells and other exogenous cells infiltrate the area. After contusion 
injury, a fluid filled cavity forms surrounded by astrocytes. 
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The glial scar matures over the first two weeks after injury and is partially 
comprised of proteoglycans such as neurocan, phosphocan, versican, and brevican [40]. 
One notable component of glial scar tissue are chondroitin sulfate proteoglycans 
(CSPGs). CSPGs create an impenetrable barrier to axonal growth in many neuronal 
systems [43]. Moreover, myelin-related glycoproteins have been associated with the 
development of an inhospitable environment for the severed axons of the CNS [44-47]. 
These factors constitute a formidable environment for regenerating axons. Conversely, 
astrocytes activated at relatively long distances from the traumatic injury act in favor of 
regeneration [48]. These cells are characterized by an increase in size and transformation 
into a more pronounced stellate shape; they also produce soluble trophic factors that 
enhance the local survival of neurons and glial cells. 
Although inhibiting formation of scar after injury appears to provide a solution, it 
is important to note that formation of scar tissue after injury to the CNS reestablishes 
homeostasis. Increases in inflammatory response, axonal dieback, and lesion volume 
were found in mice with targeted depletion of mitotic astrocytes [49]. This indicates the 
importance of a robust glial scar response. Additionally, components associated with re-
establishing the blood brain barrier after injury have been shown to provide support in the 
chronic injury environment. These factors make inhibition of the formation of scar an 
incomplete option. The cells creating the scar respond to the environment around them, so 
providing signals to minimize their activation while also delivering growth supportive 
cues to the axons may be a more complete option. 
 12 
Myelinating oligodendrocytes are damaged during the traumatic injury causing 
demyelination in the core of the injury (see Fig. 1.1). The axons directly affected by the 
trauma dieback, yet so do axons that have become demyelinated following injury. As 
mature oligodendrocytes die, endogenous oligodendrocyte progenitors are recruited to the 
area of injury, however, this population is limited in that there are too few progenitors to 
remyelinate the dying axons. In addition, dying oligodendrocytes release molecules into 
the extracellular space that normally prevent aberrant axonal sprouting in healthy tissue, 
therefore creating an excess of myelin-associated proteins (MAPs) that prevent 
regeneration. Macrophages, microglia, and oligodendrocyte progenitors are needed to 
remove these inhibitory cues from the injury environment [26, 50]. 
If the blood spinal cord barrier is broken, endogenous oligodendrocyte progenitor 
cells become hypertrophic, increase their expression of NG2, a CSPG receptor, and 
contribute to the scar. However, local oligodendrocytes also increase their production of 
molecules that encourage growth, leading researchers to believe that they may be vital in 
creating a growth permissive environment for regeneration [10, 51]. Remyelination has 
become an exciting topic for researchers in this area. Treatments that encourage 
remyelination and prevent demyelination decrease cavitation after injury and increase 
functional recovery [25, 52]. Cell replacement therapies [2, 52, 53], and pharmaceutical 
treatments [3, 54-56] have been used to attempt to increase myelination after injury, but 
providing effective remyelination has proven difficult. Limitations to the attempted 
techniques include low cell viability and undirected cell behavior as well as low local 
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retention of pharmaceuticals causing only short term effects. To study the effects of such 
treatments, researchers have turned to in vivo animal models. 
RESEARCH MODELS OF SPINAL CORD INJURY 
A significant part of this section follows closely with a previously published 
manuscript with the same author [57].  
When determining which animal model and behavioral tests to use, researchers 
have many factors to consider, including the injury being modeled, species-specific 
differences, cost, and feasibility of analysis. The detail that can be attained using 
alternative behavioral tests should not outweigh the importance of standardized 
measurement between research groups with similar goals. Comparability of the models 
and assessment is critical to translate treatment to the clinic. Further, it is important to 
recognize the importance of planning. Researchers should choose models to meet their 
goals rather than performing a barrage of tests and reporting the most significant findings.  
The therapeutic goals should match the damage expected by the model [58]. For 
example, if a treatment is designed to specifically connect rubrospinal tract neurons, a 
moderate midline contusion injury will not suffice to cause much damage to that region. 
The region of interest also needs to be chosen wisely to achieve specific deficits and to 
allow for recovery.  
Another important aspect to consider is cost. Different injury models may be 
much more expensive to implement. The Infinite Horizon Impactor is much more 
expensive than a set of aneurysm clips, and a transection model can be performed with 
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standard surgical instruments, making it even less expensive. Furthermore, the cost of the 
species used, and the cost of post-operative animal care should be considered.  
  Behavioral assessment should be performed to assess functional deficit and 
recovery in combination with histological assessment. Behavioral assessment can 
elucidate the influence of the damage and repair of the tissue on overall function. 
Different models can make some analysis more easily performed or relevant; for 
example, transection models can be advantageous to eliminate axon sparing, but 
sprouting and axon sparing are more relevant in a contusion model. Transection models 
create a space for placement of pre-formed biomaterials, but if a treatment is injectable, a 
contusion model may be advantageous to more closely mimic clinical injuries. 
It is important to consider the leading causes of morbidity and mortality among 
rodent test subjects. Autophagia is common for all injury models [59, 60]. Respiratory 
tract infections and decubitus ulcers are also concerns for researchers working with 
cervical SCI [61]. Urinary tract infections are less prevalent with cervical than with 
thoracic SCI models but should still be monitored [61].  
Rodent models cannot predict exactly how human patients respond to SCI 
physiologically or functionally; however, they provide an early assessment platform for 
treatment and physiological damage after SCI. Human SCI is very complex and there is 
an appreciation among researchers that the models cannot mimic the injuries perfectly, 
nor can they expect all behavioral symptoms observed in humans to have correlates in 
animals, or vice versa. It is important to examine behavioral deficits in rodents, even 
without a human correlate, to determine if there is a functional change. Although humans 
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may not show an obvious vibrissae-elicited placing reaction, this test can reveal a loss, 
and a return, of sensory and motor communication between the brain and spinal cord. An 
animal’s ability to perform in different tasks can reveal specific tracts that are 
regenerating, even if they are not in the same location in the human spinal cord. This can 
reveal a promising treatment that can then be tested further on higher species or directly 
on humans in a hope to help with recovery. It must be kept in mind that treatments that 
rescue neurons from degeneration may sometimes have an adverse effect on functional 
outcome [62]. 
Types of injury 
A significant part of this section follows closely with a previously published 
manuscript with the same author [57].  
Rodents are commonly used for spinal cord injury models to help predict 
functional outcomes of neurological disorders and injuries. Many of the functional 
behavior outcomes appear after SCI in rodent models parallel clinical symptoms 
observed in human SCI patients to a remarkable degree. About 62% of clinical spinal 
cord injuries are at the cervical level [16]. Therefore, there is a desperate need for 
unilateral cervical spinal cord injury rodent models to assess the potential of treatments to 
help the majority of SCI patients regain function. In addition, treatments aimed at 
improving functional recovery can be more adequately evaluated by using different 
injury models and sensitive behavioral assays that target the site and extent of injury. 
Some research models are considered more clinically relevant than others; however, it is 
important to remember that human SCI is very complex, and many different injury types 
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occur in human patients. Understanding the strengths and limitations of the animal 
models will allow more relevant analysis of the injury, behavioral sequelae, and 
therapeutic approaches. 
There are three main surgical injuries used to model SCI: contusion, 
compression, and transection. In rat models, contusion and compression injuries form a 
cavity after injury as the glial scar forms and demyelination occurs (see Fig. 1.1). 
Transection surgical models introduce an immediate artificial cavity which quickly 
acquires similar glial scarring and infiltration of exogenous cell types (see Fig. 1.1). 
Contusion and compression injuries are the most common forms of SCI in 
humans. Researchers can create these injuries using balloon compression, spring-loaded 
clips, and computer-controlled impact. These devices can be controlled for force of 
impact and dwell time that the force is applied. Each contusion model has strengths and 
weaknesses (see Table 1.1). This allows researchers to tailor the injury to their specific 
goals.  
Balloon compression models are advantageous because they can precisely control 
the time and force of the compression and can be performed percutaneously, without a 
laminectomy. This model mimics a burst intervertebral disc or cystic injury in humans. 
The compression models used in rodent models are often not considered relevant because 
the decompression occurs much earlier than would occur in clinical SCI cases [63-65]. 
Spring-loaded clip models also allow good control of the time and force of the injury and 
are easy to perform with precise placement [66]. This is one of the most inexpensive 
options for compression or contusion injury models. However, clip compression models 
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require extensive decompression of the spinal canal, which may cause further damage or 
inflammation. Compression injuries can also be performed with modified surgical 
forceps to create a reproducible functional deficit, and are more commonly used in a 
thoracic injury model [67, 68]. Static weight compression is another model in which a 
known weight is placed gently on the spinal cord and held there for a controlled period of 
time [69]; because there is less acute damage, this model is not as clinically relevant, but 
still provides important information regarding the damage of compression alone. Taken 
together, the balloon and spring-loaded clip models are especially useful in assessing the 
most optimal decompression time after injury [63, 64, 70] and have helped change the 
treatment of human patients after SCI. Prior to 1997, surgery was not performed as 
quickly as possible on patients in fear of doing further harm, but currently, patients are 
rushed into surgery to remove pressure from the spinal cord to prevent further damage 
[64].  
Although transection models are considered less clinically relevant, they allow 
researchers to precisely affect tracts and enable the most accurate assessment of 
functional recovery with the ability to tailor behavioral tests based on the axon tracts 
affected. Dorsal hemisection [71], dorsal quadrant transection [72], lateral hemisection 
[73], dorsal column transection [71] have been performed. These models are especially 
useful for assessing axon regeneration because the amount of axon sparing should be 
minimal or controllable, especially if a complete transection is performed. Transection 
models are usually performed with precision to remove specific tracts or areas of tissue. 
For example, if researchers wanted to compare and assess the ability of various treatment 
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options to support regeneration of the rubrospinal tract, a quadrant or lateral hemisection 
can be very useful to guarantee that no axon sparing occurs. SCI lateral hemisection 
models include a lesion that removes half of the tissue laterally and is generally 
performed manually by the experimenter. This model has similar deficits as the human 
Brown-Sequard syndrome, in which half of the body loses function, whereas the other 
half of the body retains function [74, 75]. Researchers have used transection models to 
examine multiple treatments, including biomaterials [76], drugs or growth factors [77], 
and stem cell transplantation [78]. Dislocation [79], and ischemia [80], have also been 
modeled anatomically and behaviorally.  
Computer-controlled impactor injury models are generally recognized as the most 
clinically relevant contusion models [81] and are well suited for measuring functional 
deficit. There are many different devices available for this model: (1) the MASCIC 
device uses a weight drop technique with different heights to control the severity of the 
lesion and has been well characterized for thoracic SCI [58], (2) the OSU device controls 
the displacement of the head to control severity of the lesion [82, 83], (3) the PinPoint 
device from Hatteras allows control over velocity and displacement, and was originally 
described for thoracic injury [84], and (4) the Infinite Horizon Impactor, which controls 
applied force to control the severity of the lesion and has been thoroughly characterized 
in both thoracic [85] and cervical SCI [86, 87]. These approaches can all be used to create 
reproducible lesions; however, the necessary equipment can be expensive to purchase and 
the techniques require extensive training for proficiency. These models have been used to 
examine functional deficits and correlate them to histopathology [86, 87] to examine 
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demyelination [88], and as a means to assess biomaterial delivery [89] and cell delivery 




Table 1.1: Pros and cons of surgical animal models.  
Differences in surgical models allow researchers to choose the surgical model to best 
study their goals. 
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A significant part of this section follows closely with a previously published 
manuscript with the same author [57].  
Researchers also need to determine which behavioral tests are most relevant for 
their species, model, and study goals. Just as models will show deficits based on which 
tracts are affected, behavioral tests are sensitive to specific functional deficits. For 
example, if a model damages the corticospinal tract only, the animal’s locomotion should 
not be seriously affected, so behavioral tests examining locomotion should not be 
exclusively used. Similarly, physical therapists and physicians examine human patients 
using the American Spinal Injury Association (ASIA) scale to look at specific deficits. 
This scale is used to determine the extent and level of injury for patients [17]. Patients are 
rated on specific functions that are associated with levels of the spinal cord (e.g., C5 is 
associated with bicep strength) and given a score of 0-5 where 0 is complete paralysis, 
and 5 is normal function. Scores of all of the tested functions are then combined to give 
them an overall score from A-E where A is complete paralysis (including sensory 
function) and E is normal function. Behavioral tests should be chosen to assess a range of 
functionality relevant to the injury model. 
Vibrissae-elicited placing is a commonly used test to examine the sensorimotor 
function after spinal cord injury in rats [73, 91]. This test involves stimulating the 
whiskers on a table edge to elicit a motor response of the animal placing its forepaw onto 
the table to gain stability. A graded score of 0-4 is assigned based on the extent of 
movement of the limb being tested where 0 describes complete paralysis, and 4 
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represents normal function. This test can indicate the integrity of motor and sensory 
tracts. This test eliminates the possibility of a reflex response being elicited by 
stimulating a sensory route not directly associated with the forelimb. Therefore, this test 
can reveal that a motor tract is intact along the distance it travels from the brain. Based on 
the level of function, this test may also reveal the extent of damage to the cross-sectional 
area of the motor tract.  
Contact placing is similar to vibrissae-elicited placing and involves a light touch 
to the paw from which the motion is being elicited; this test has been performed on rats 
[92] but is difficult to perform on mice. This involves a light touch that does not signal 
the pressure sensory nerves in the skin to elicit a response, and the experimenter must be 
careful to not move the limb or any joints during testing. This test can show if there is a 
reflex; however, it will not differentiate between a reflex and a complete tract connection, 
where the tactile information is transmitted to the brain prior to eliciting the response. 
This test is similar to the tests performed for the ASIA scale used for SCI patients to 
determine if they can feel light touch. In human patients, they are asked to tell the doctor 
if they feel the light touch; however, with animals, that is not possible, so this test 
incorporates motor movement as the signal to show that the light touch is perceived.  
Proprioceptive placing indicates whether the reflex arc is still present. If the 
animals are able to respond to light touch, this test will not work because they will 
respond before there is motion of the limb. The test has been performed on rats [92] but is 
difficult to perform in mice. By stretching the tendon as a joint is extended, a reflex 
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response is elicited. This is similar to the reflex tests performed for the ASIA test in 
human SCI patients.  
Limb use asymmetry during vertical-lateral exploration in a cylinder (20 cm 
diameter, 30 cm height for rats; 11 cm diameter, 20 cm height for mice) is an easy, 
inexpensive test to determine whether the animal has a preference in its limb use; this test 
has been used extensively in rodents [73, 87, 91, 93-95]. The cylinder test involves 
allowing the animals to move naturally and to vertically explore the walls around them 
while the experimenter records which limbs are used for weight supported stepping on 
the wall. This allows a clear determination of sidedness in natural function. This would 
allow experimenters to determine which side of the animal was more affected by the 
injury, and in the case of unilateral injuries, it allows the experimenters to determine the 
level of use of the ipsilesional limb versus the contralesional limb.  
Swim tests can reveal functional deficits in forelimbs and hindlimbs. Normal 
rodent behavior when swimming to an escape platform consists of the rat holding both 
forelimbs forward under its chin in a planing position while stroking with its hindlimbs 
[96]. With a deficit in the forelimbs, an animal will not be able to plane their forepaws. 
This can result in one limb dragging. For cervical SCI injuries, this test is very reliable to 
determine presence of forepaw planing behavior, the angle of a limb that is not planing, 
and deficits in hindlimb stroking motions [93].  
Open-field locomotion is used to assess the animal during normal functional 
movement. This involves observing and analyzing the position and weight support on 
individual forelimbs during uninterrupted locomotion. These tests are sensitive to the 
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amount of limb use when the animals are behaving naturally. One well standardized open 
field test is the Basso, Beattie, and Bresnahan (BBB) test [97]. Although, it is more 
appropriate for thoracic injuries, it has been used in injury models at a low cervical level 
as well [98]. There are a few open-field locomotion tests that are more specifically 
designed for cervical injuries, including the forelimb locomotor scale (FLS) [99], 
forelimb locomotor assessment scale (FLAS) [100], and another assay developed by a 
group at the University of Provence in Marseille, France [101]. Each test provides a score 
for different behaviors that are sequentially categorized based on forelimb function, 
including weight support on the limbs, paw position and orientation, and swinging 
motion. These tests observe animals in a similar situation to human locomotion because 
they do not use forced motion of the ipsilesional limb and allow the animal to 
compensate for the injury the way they usually compensate while moving on their own. 
Compensation occurs frequently in rodents and humans to increase speed, efficiency, or 
accuracy of a movement but does not exercise or demonstrate the functional ability of the 
ipsilesional limb. 
Forepaw dexterity tests show fine motor movements and reveal paw strength and 
function. Animals can use their paws differently based on the model and the tracts 
affected. Similarly to human deficits, some animals cannot grip an object, and some 
cannot release their grip on an object. Some can move individual digits while others have 
only moderate wrist or shoulder function. A few pasta tests have been developed to 
reveal these differences. The Jones, Whishaw, and Bresnahan groups have developed 
tests to examine individual digit function [102-104], while the Schmidt group uses a 
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similar pasta type to examine overall forelimb function [73, 105]. Other handling tests 
use different foods, including macaroni pasta, peanuts, and grapes among others to 
examine functional deficits. Time to eat the object, forepaw use, and individual digit 
motion are all examined in these tests. Improvement can be quantified as the animals 
increase use of the ipsilesional limb. These are similar to human SCI patients’ abilities to 
grip and manipulate objects. The ASIA exam includes finger strength and abduction 
assessment to determine injury level [17]. 
Forced motion tests have been developed to assess the functional abilities of each 
forelimb while preventing compensation with the other limb. The postural instability test 
(PIT) and a forelimb alternation test have been used to examine forelimb function during 
forced forward motion [73, 105]. In this assay, the experimenter holds the rat above a 
table with one of the rat’s paws on the tabletop and moves the rat forward over its center 
of gravity. Then the position along this path at which the rat places its paw down after 
stepping forward is noted. Test scores depend on the distance the animal traverses before 
motion is elicited, while the animal is moved forward with only forelimb support, 
showing improvement as the score aligns with the pre-op distance. These tests allow 
researchers to examine an animal’s ability to use the limbs while removing the chance for 
compensation with the other limb, giving the experimenter an understanding of actual 
functional abilities whether or not the animal has been compensating for that same 
motion. This is more comparable to clinical tests, as most of the tests performed on 
patients examine a patient’s ability when they consciously attempt to make individual 
movements. 
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Grooming tests [86, 87] can be used for sensory-motor assessment. This test 
examines the rats’ response to water applied on the face and upper back. The test is 
scored based on the animal’s skill level and dexterity while grooming itself. Unlike the 
forelimb placing tests where the response is a reflex, the action during a grooming test is 
a conscious response to the sensory irritant. Grooming in normal animals follows a 
specific behavioral procedure, starting with licking the forepaws, cleaning the nose, face, 
behind the ears, and then the upper back. The rat’s ability during this pattern of behavior 
determines the test score. 
This is by no means a comprehensive review of rodent models and behavioral 
assays; many other functional behavioral tests exist. Additionally, this dissertation does 
not cover many sensory tests that should also be considered. The dot patch removal test 
[71, 91, 93], Von Frey hairs [60], and heat test [106] can all elicit responses to sensory 
input and may provide insight to hyperalgesia [107].  
Many surgical models exist to study SCI in rodents; however, it is important to 
assess the goals and expectations of the experiment before choosing a model. Similarly, 
behavioral tests need to be chosen carefully to ensure that a researcher is examining a 
relevant function. It can be tempting to use a barrage of tests and report the tests that 
show the most promising or significant results, but this approach to determine the 
recovery after SCI is not scientifically sound. Each aspect of a study should be planned 
before the experiment, and a pilot study is recommended to provide insight into what is 
expected from each model and treatment to minimize animal use and unnecessary 
experimental time during the experiment. 
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CURRENT RESEARCH ON SPINAL CORD INJURY 
Current research includes the examining the anatomical effects of spinal cord 
injury (SCI) and the cellular and extracellular matrix response to the injury. The 
reduction of scar formation is important to prevent and treat demyelination, and to 
encourage regeneration. The scar that forms after spinal cord injury segregates that injury 
area from the spinal cord, preventing toxins from entering the healthy spinal cord tissue, 
but also prevents regenerative growth of axons. Minimizing this barrier to regeneration is 
critical to restoring function. Other research has examined mediating demyelination 
around the injury area to prevent axonal dieback and to encourage functional recovery 
after injury. Many different approaches have been taken to address regeneration and 
functional recovery after SCI; this dissertation discusses two treatment options, (1) cell 
delivery to and near the injury area and (2) biomaterial delivery.  
Cell delivery  
Several cell types have been examined to assess their potential to reduce scar 
formation, enhance tissue sparing and remyelination, and encourage regeneration 
including but not limited to Schwann cells [41, 108], olfactory ensheathing cells [109, 
110], and neural progenitor cells [52, 111].  
Schwann cells have been utilized for transplantation therapy after spinal cord 
injury in animal models since 1981 [112]. Many studies have examined remyelination 
and axonal regeneration with Schwann cell transplantation because Schwann cells are the 
myelinating cells of the peripheral nervous system. More recently, invasion of host 
Schwann cells after cell transplantation has also been considered as a contributor to 
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regeneration. The host Schwann cells behave similarly to transplanted cells providing 
natural signals to host CNS tissue to encourage regeneration [42]. Schwann cells used for 
transplantation are isolated from many sources, including adult and postnatal nerve and 
derived from induced pluripotent stem cells making them an exciting option for clinical 
translation. However, Schwann cell myelination exhibits a different phenotype than 
central nervous system myelin with inclusion of the Schwann cell cytoplasm. Each 
myelinating cell type expressed different proteins and morphologies during axonal 
interaction [113].  
Biernaskie et al examined the effects of skin-derived Schwann cells on scarring 
after thoracic contusion injury in rats [108]. Cells were injected directly to the lesion 
epicenter to provide signals directly to at the scar site. There were increased numbers of 
axons growing through the lesion and myelination was more prevalent in animals treated 
with skin derived Schwann cells. Additionally, endogenous Schwann cells were recruited 
in high numbers to the lesion area to encourage regeneration. This study examined 
behavioral recovery after treatment and found an increase in Beattie Basso and Bresnahan 
(BBB) score with skin derived Schwann cell treatment, however, no increase in other 
behavioral test scores. This research showed an increase in spared white matter with skin 
derived Schwann cell transplantation. These results imply that the Schwann cells 
provided support to the myelinated tracts of the injured cord and possibly decreased 
demyelination, however, myelination of the growing axons was of the peripheral nervous 
system type [108].    
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After contusion cervical spinal cord injury in rats, Schaal et al transplanted 
Schwann cells to the injury area one week post injury [114]. They observed tissue 
sparing, more reticulospinal axons traced by anterograde dye injection to the lesion site 
implies growth and sparing into the lesion area. Additionally, in this study they assessed 
functional recovery. Recovery based on the BBB test was not observed, however, with 
forelimb grip strength, an improvement over untreated groups was observed. This is 
promising for Schwann cell treatment. This was an 8 week experiment to examine 
functional recovery and tissue sparing. Little growth was observed past the lesion [114], 
this may be related to the ECM deposited by Schwann cells, which has a high laminin 
content [115, 116].  
The Bunge group out of the Center to Cure Paralysis in Miami, FL has 
extensively studied Schwann cell transplantation into rat models of SCI and is currently 
in collaboration with physicians performing clinical trials with this cell type in SCI 
patients. Pearse et al transplanted Schwann cells to the injured area of a contusion 
thoracic spinal cord injury model in rats and found dense regions of myelinated fibers 
where the transplanted Schwann cells were present [42]. However, the low cell survival 
(<5%) by the third week after transplantation, possibly related to the lack of ECM 
components in the lesion center, implies that the procedure requires further optimization. 
This research also showed evidence of invading Schwann cells in the contusion model 
used [42]. Invading Schwann cells have been shown to contribute to myelination in the 
lesion area after SCI [117, 118]. 
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Schwann cells have also been applied to thoracic dorsal column transection where 
experimental groups treated with Schwann cells had increased numbers of myelinated 
axons traversing the lesion area. Imaizumi et al examined the effects of olfactory 
ensheathing cell and Schwann cell transplantation rostral and caudal to the injury area 
after spinal cord injury on electrophysiological function in rats [119]. Amplitude and 
number of action potentials detected increased with transplantation of each cell type 
indicating an increase in signal transduction. Assessing functional recovery in this way 
allows quantitative anatomical assessment of the therapeutic effects. The Schwann cell 
transplant group exhibited increased myelin fiber number and more thickly myelinated 
axons with peripheral phenotype, as was expected with the transplant type. Olfactory 
ensheathing cells are often studied as an example of a more central nervous system-type 
myelinating cell, however, their contribution to myelination is often limited. 
Transplantation of olfactory ensheathing cells results in an increase in axon number 
through the lesion area and tighter myelination compared to Schwann cell transplantation. 
In both cases, experimental groups had increased axonal growth and myelination 
compared to a lesion alone [119], implying that both cell types hold promise to restore 
myelination and protect tissue surrounding a lesion if transplanted after injury.  
Olfactory ensheathing cell transplantation has been combined with behavioral 
training to examine functional effects [120]. The myelinating phenotype of the olfactory 
ensheathing cells provided support to the tissue surrounding the lesion and increased 
sparing of white matter while providing minimal remyelination. Though the animals were 
trained for 4-7 months after injury, there was little regeneration beyond the lesion site. 
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The researchers did find, however, increased white matter sparing and regenerated 
noradrenergic and serotonergic axons through the injury area. Functionally, the animals 
were scored using the BBB scale and found to increase their plantar stepping ability with 
olfactory ensheathing cell transplantation compared to media transplantation and training 
alone. A combined treatment of olfactory ensheathing cell transplantation and functional 
training further enhanced these effects, implying an importance for task-specific training 
[121]. 
 Neural progenitor cell transplantation has also been recently explored as a 
treatment for spinal cord injury and may provide a more promising contribution to native 
myelin if differentiated appropriately. The cell populations used in these studies can be 
isolated from a variety of locations, including the forebrain to the spinal cord. 
Additionally, passages and culture conditions prior to transplantation are inconsistent 
between groups. Differentiation of these cells post transplantation has varying reported 
results, some researchers report high astrocyte populations [122, 123] while others report 
high oligodendrocytes [52, 124]. Many of the studies reporting high oligodendrocyte 
differentiation also include delivery of growth factors and differentiation directing agents 
to the injured area of the spinal cord. One of the most crucial issues documented in many 
of these experiments is low cell viability after implantation. Survival rate as low as a 
4.6% have been reported [52]. However, the transplantation of these cells tends to 
provide positive results behaviorally and histologically, implying that even a small 
population of neural progenitor cells can provide a regenerative effect.  
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 Parr et al transplanted adult neural progenitor cells to the lesion site of a thoracic 
compression injury model in rats nine days post injury and reported a significant increase 
in BBB score with neural progenitor cell transplantation [52]. A high percentage of the 
transplanted cells differentiated to oligodendrocytes (~63%), however, only about 4.6% 
of the cells survived for 7 days and the 12 week group showed an average of 1.2% cell 
survival [52]. Conversely, Vroemen et al reported neural progenitor cell survival after 
transplantation to the transected dorsal corticospinal tract, however, they did not report 
quantified results [125]. They reported significantly higher astrocytic differentiation of 
neural progenitor cells in this model. For this experiment, they examined cell 
proliferation after transplantation and reported minimal proliferation at three weeks post 
injury. Additionally, this experiment revealed the tendency of transplanted cells to remain 
around the edges of the lesion, most likely due to the lack of a supportive scaffold being 
present in the injury area [125].  
 Undirected differentiation is a significant problem with transplantation of neural 
progenitor cells. Pfeifer et al reported about 90% differentiation to astrocytic phenotypes 
four weeks after transplantation of autologous and allogenic adult neural progenitor cells 
to a cervical dorsal column transection model [126]. With neural progenitor cell 
transplantation, there was an increase in axonal sprouting to the lesion area compared to 
lesions with fibroblast transplantation [126]. This undirected differentiation may be 
controllable with transplantation of ECM signals with the cells. Signals similar to those 
present during development may lead NPCs toward specific phenotypes. 
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 The Shoichet group recently applied neural progenitor cells rostrally and caudally 
to the lesion site of a thoracic compression model of spinal cord injury in rats [111]. They 
report a significant decrease in cavitation but low transplanted cell survival (0.4-1.2%). 
Many of these cells differentiated toward oligodendrocytes (~59%) when transplanted 
with an inert biomaterial functionalized with platelet-derived growth factor, indicating 
the importance of directing the differentiation of the transplanted cells toward 
oligodendrocytes. This experiment showed a 33% increase in axonal sparing when the 
neural progenitor cells were directed to differentiate toward oligodendrocytes compared 
to cells transplanted without specific signals [111]. This study introduces the possibility 
of transplantation with specific signals from a biomaterial, however, previously, 
researchers have transplanted cells with biomaterials that released growth factors. In most 
previous cases, the growth factors were not conjugated to the biomaterial. Lu et al 
transplanted neural stem cells in a fibrin matrix to a transection model of spinal cord 
injury and reported connectivity of the graft, axonal regeneration through the graft, and 
functional regeneration seven weeks after transplantation [89]. There was significant cell 
survival after transplantation and many of the neural stem cells differentiated along a 
neuronal lineage. A cocktail of growth factors were also included in the transplantation 
therapy, so the cause of this directed differentiation and cell survival is unclear [89]. The 
signals present directed cell behavior and provided a scaffold to prevent cell death. 
 These experiments provide significant motivation to examine cell transplantation 
in combination with biomaterials. The exciting results from experiments where NPCs 
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were transplanted with biomaterials also provide insight to methods that may assist in the 
direction of neural progenitor cell differentiation in vivo. 
Biomaterial delivery 
 More recently, research has begun to focus on the mode of cell delivery in an 
effort to improve problems with cell viability [52], uncontrolled cell differentiation, and 
activation of transplanted and endogenous cells [120] after CNS injury. Biomaterial 
scaffolds can mitigate a number of these issues by eliciting desired cellular response by 
providing cues to cells during migration [127], differentiation [128], and regeneration 
[129, 130]. Hydrogels can provide benefit to the endogenous cells surrounding the 
implant site as well as the transplanted cells while acting as a delivery vehicle for cells 
into injured areas of the nervous system [89, 131].  
Biomaterials for use in the CNS should create a permissive environment for 
growth, act as a suitable carrier for cells, and integrate into functional new tissue. Such 
biomaterials are usually applied in anatomically contained locations, such as in a SCI 
cavity [132] and used to deliver cells as replacement therapy to integrate into host tissue. 
Many researchers report increased cell viability upon delivery of cells within a 
hydrogel along with other positive effects in many injury models. In a study discussed 
above using a complete transection model of thoracic SCI, Lu et al. showed success at 
increasing transplanted neural stem cell viability as well as functional recovery after 
spinal cord injury with the delivery of neural stem cells in a fibrin matrix compared to 
cells alone [89]. Patel et al reported increased cell viability when transplanted using an 
injectable collagen laminin hydrogel to deliver Schwann cells to the lesion site after 
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contusion spinal cord injury. This study systematically examined cell survival, 
proliferation, graft vascularization, and axonal ingrowth with and without the hydrogel 
delivery vehicle. By suspending the cells in a matrix prior to transplantation it was 
possible to observe increased cell survival (27% versus 14%) and an increase in axonal 
ingrowth and vascularization in the lesion area. These results indicate the importance of a 
supportive growth environment for regeneration. Using biomaterials as a delivery vehicle 
increased cell viability to encourage tissue replacement and regeneration [133]. 
Beyond effects on cell viability, it is important to examine how components and 
characteristics of the biomaterial used will affect cellular behavior. For example, when 
researchers implant stem or progenitor cells, it is advantageous to direct the 
differentiation of the cells toward a desired phenotype. In 2006, Engler et al examined 
cellular differentiation in response to matrix stiffness and found the differentiation of 
mesenchymal stem cells could be modulated by changing only the mechanical stiffness of 
the substrate on which they were cultured [128]. Differentiation toward bone, muscle, 
and neural lineage occurred on stiff (25-40 kPa), medium (8-17 kPa), and soft (0.1-1 kPa) 
substrates, respectively [128]. Following that work, other researchers examined the more 
precise differentiation of cell types within specific tissue types. Neural progenitor cells 
can differentiate along a glial lineage (astrocytes or oligodendrocytes) or along a neuronal 
lineage. Researchers have begun to delve into the specific mechanical environments most 
ideal for differentiation into each cell type. Seidlits et al showed that the mechanical 
properties of the material can direct differentiation of NPCs toward different neural 
lineages with hyaluronic acid-based materials with similar mechanical properties to brain 
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and spinal cord tissue [134]. Softer materials (~3 kPa) tended to direct differentiation 
toward neuronal lineage whereas astrocytes were the most prevalent cell type in materials 
with a higher compressive modulus (~5 kPa) [134]. Many of the experiments to assess 
NPC response to the mechanical properties of the environment were performed in vitro 
and not translated to in vivo models. The results provide insight to the response of stem 
and progenitor cells to differences in mechanical stiffness of the scaffolds without any 
other specific cues. 
Oligodendrocyte response to mechanical cues has also been studied to determine 
the mechanobiology of demyelinating diseases [28]. Oligodendrocyte progenitor cells 
were examined in culture on substrates of varying stiffness to assess the effects of the 
mechanical environment on proliferation, migration, differentiation and survival. Cell 
stiffness, migration, survival, adhesion, and differentiation were assessed on 
polyacrylamide gels ranging from 0.1-70 kPa in compressive modulus. Though there was 
little correlation between cell stiffness and substrate mechanical properties, there was an 
increase in cell stiffness with differentiation was observed. In this study, researchers 
examined cell migration using time-lapse imaging and found that cells migrate more 
quickly on stiff substrates (70 kPa), proliferate most efficiently on 0.7-70 kPa substrates, 
and have the highest survival rates on intermediate stiffness substrates (0.4-1 kPa). To 
examine correlation of cell differentiation and substrate stiffness, this study used 
immunocytochemical markers for specific ranges of oligodendrocyte lineage and found 
that the most efficient substrate stiffness to develop mature, myelinating 
oligodendrocytes was 0.4-1 kPa [28]. This study elucidates the importance of the 
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mechanical environment on determining the behavior of oligodendrocyte progenitor cells 
and implies the mechanosensitivity of oligodendrocytes throughout development. 
Aside from mechanosensitive properties of cells, cellular response to the chemical 
environment has also been extensively studied, particularly with regard to myelin 
development. Mothe et al, discusses the importance of chemical cues from the 
environment to direct differentiation and increase cell survival after transplantation and in 
culture [111]. In this study, growth factor cues were provided locally by conjugating 
platelet-derived growth factor to a hydrogel with a base of methyl cellulose, an inert, 
biodegradable compound. The hydrogel was optimized to increase oligodendrocyte 
differentiation, mainly by adjusting conjugated platelet-derived growth factor 
concentration [111]. They previously measured the hydrogel’s response to shear stress 
and reported the storage modulus as less than 200 Pa [135], implying that these were soft 
materials that behave more like a solid than a liquid but do not provide significant 
mechanical stability. Additionally, the hydrogel composition included hyaluronic acid, a 
native extracellular matrix component discussed in more detail below, which provides 
cues to neural progenitor cells. The interaction of the immature neural progenitor cells 
with the hyaluronic acid may provide direction to the differentiation after transplantation. 
Biomaterials are also delivered to impart effects on the surrounding tissue 
themselves. Hyaluronic acid hydrogels have been shown to decrease scar formation after 
transplantation into the spinal cord injury area [15]. In this study, a photocrosslinked 
hyaluronic acid hydrogel was transplanted to the injury site of a thoracic transection 
spinal cord injury. Astrocyte activation is limited after transplantation with hyaluronic 
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acid based hydrogels. Additionally, chondroitin sulfate proteoglycan staining showed a 
decrease in this molecule, which creates a chemical barrier to axonal growth. 
Approximately 50% fewer macrophages (ED1+) cells were present in treated groups 
compared to control injury groups on 1, 3, and 10 days [15]. This reveals some 
advantages to using specific molecules while designing a biomaterial for central nervous 
system regeneration, however, there are also disadvantages to using hyaluronic acid 
alone.  
Hyaluronic acid is not innately cell adhesive. Immature cells migrate on 
hyaluronic acid, whereas adult cells do not express surface receptors capable of binding 
hyaluronic acid. Therefore axons and mature cells would not migrate in the area of a 
biomaterial made primarily of hyaluronic acid. Additionally, hyaluronic acid has been 
implicated in the inhibition of oligodendrocyte maturation [33, 34], so particularly with 
the goal of preventing demyelination and assisting with remyelination, the presence of 
hyaluronic acid should be controlled. Hyaluronic acid presence during the first two weeks 
of scar formation may be important to prevent proliferation and expansion of the 
astrocytic scar. Long term retention of HA can pose a detriment by preventing axonal 
regeneration through the lesion area, therefore diffusion of this component is optimal. 
Particularly with respect to oligodendrocyte differentiation, it would be advantageous if 
the hyaluronic acid could diffuse from the lesion area. Researchers have shown the 
importance of this particular extracellular matrix component with respect to neural 
progenitor cell migration [13, 35, 136]. These effects on cellular behavior parallel 
developmental levels of hyaluronic acid. During development, this component is present 
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in high concentrations in spinal cord extracellular matrix, whereas healthy mature spinal 
cord tissue has low levels of hyaluronic acid [13, 137]. 
Other native extracellular matrix components are important to direct cell 
behavior. Specifically, cells require adhesive components to migrate and regenerate 
during healing. During development, neural progenitor cells have been observed to 
migrate along forming blood vessels. These immature blood vessels have high levels of 
laminin I and collagen IV, which make up the basement membrane of the mature vessels 
[6-8, 138]. Such migratory cues during development may provide cues for differentiation 
as well as for axonal growth. One powerful example of the importance of such bioactive 
cues is the response of cells to the presence of laminin. Kofron et al examined the effects 
of laminin presence on neurite extension with CSPG presence and found the neurites 
extended near the CSPG coated substrates when laminin was present but not without that 
presence [139, 140]. Similarly, Yu et al examined the effects of laminin and 
chondroitinase, an enzyme that can erode CSPGs, on the bioactivity of CSPGs. Dorsal 
root ganglia neurites extend into the hydrogel that otherwise presented only growth 
inhibitory signals if laminin or chondroitinase was present [141]. These experiments 
indicate the importance of extracellular matrix cues on regenerative growth. 
Biomaterials made of natural components that parallel the developmental 
extracellular matrix cues may provide an ideal environment to direct the behavior of cells 
when transplanted to the injury area after spinal cord injury. Although growth factors and 
chemicals can be used to direct cellular behavior in culture, they are impractical for 
sustained delivery to the transplant site. Delivery with biomaterials that provide natural 
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extracellular matrix cues may be an ideal way to stimulate cellular behavior locally in a 
sustained manner. By controlling the mechanical properties and composition of such 
biomaterials, differentiation can be directed in vivo after transplantation. 
Considerations for transplantation  
Delivery of a therapy to the injury site after trauma to the spinal cord needs to be 
considered. Pre-formed biomaterials can be placed in experimental transection models 
where the lesion shape and size is somewhat controllable, however, in contusion and 
compression models, as well as in the clinic, this is not a viable option. To deliver a 
preformed matrix to such models, secondary injury would be required as the surgeon 
would have to excise tissue above the lesion site to place the material into the cavity. 
Additionally, these preformed materials would not form to the injury site exactly, 
therefore, the edges would not all interact with the material. An injectable material would 
conform to the irregular shape of the injury, whether transection, contusion, or 
compression and provide an interface between the therapy and the scar tissue in the lesion 
[142].  
Another advantage to injectable substrates is the ability to evenly distribute the 
desired therapy to the injury area and control the release. Injectable cells can be evenly 
suspended in the matrix prior to injection, providing a more favorable environment for 
cell interaction. With this interaction in mind, the matrix should also be designed to allow 
for cell infiltration after transplantation. Injection time is a factor that needs to be 
considered, fast gelling is optimal for in vitro experiments, but for in vivo transplantation 
a slow injection rate is necessary to prevent sudden pressure increase to the lesion area.  
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SUMMARY 
There are many promising research areas for treatment after spinal cord injury, 
however to date, a viable treatment has not been developed. Many factors are important 
for the delivery of a therapy, but a combination therapy is needed to see significant 
results. Factors to consider when developing a combinatorial treatment include the 
interaction between the treatments and the timescales of interaction. Research has 
recently shifted from studying specific treatments to combining treatments and therapy 
delivery methods. With this development, the field of engineering has the technology to 
assist and collaborate with the neuroscience field to deliver cells and growth factors to 
injury areas after spinal cord injury. The use of biomaterials provides researchers with the 
ability to modulate more parameters and create a more favorable environment. 
Mechanical cues, chemical cues, cellular interaction, ingrowth, and distribution can now 
be controlled to deliver appropriate cues to the regenerating nervous system. 
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SPECIFIC AIM 1: OPTIMIZE A NOVEL INJECTABLE HYDROGEL COMPRISED OF 
EXTRACELLULAR MATRIX COMPONENTS TO MIMIC MECHANICAL AND BIOCHEMICAL 
PROPERTIES OF NATIVE SPINAL CORD TISSUE.  
Develop protocols for multi-component hydrogel production with desired gelation 
kinetics for injectable in vivo delivery.  
Tune mechanical properties of hydrogels to closely mimic native postnatal spinal 
cord tissue. 
Examine hyaluronic acid release from the hydrogels.  
SPECIFIC AIM 2: EXAMINE THE DIFFERENTIATION OF NEURAL PROGENITOR CELLS 
TOWARD OLIGODENDROCYTES EMBEDDED IN DIFFERENT HYDROGEL COMPOSITIONS. 
Examine the effects of hydrogel composition on cell differentiation. 
Modulate hydrogel properties to induce >50% NPC differentiation to 
oligodendrocytes. 
SPECIFIC AIM 3: IMPLEMENT AN INJECTABLE HYDROGEL-CELL SYSTEM INTO AN IN 
VIVO MODEL TO ASSESS FUNCTIONAL AND ANATOMICAL RECOVERY AFTER SCI. 
Develop a unilateral, cervical contusion spinal cord injury model to mimic clinical 
injuries. 
Assess functional recovery after hydrogel and cell implantation using behavioral 
assays. 
Analyze cellular and anatomical differences between groups after hydrogel and cell 
transplantation to find correlates between functional and anatomical recovery. 
RATIONALE  
Cells respond to chemical and mechanical cues to differentiate, migrate, and 
proliferate. Using biomaterials, chemical and mechanical properties of native tissue can 
often be mimicked to achieve similar responses. Progenitor cells have been transplanted 
into the injured spinal cord and have been shown to improve functional recovery [2, 52]; 
however, cell viability is low (~1.6%), and there is little growth of axons into the injured 
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area [52]. With a 3D matrix to deliver cells in vivo, cell viability can be increased and a 
growth supportive environment provided for axonal regeneration. Previously, the 
Tuszynski group has introduced human neural stem cells in a fibrin matrix to injured rat 
spinal cords and found that the cells promoted functional recovery [89]. Combining 
matrix components that are more native to the spinal cord (HA and laminin) should 
provide a matrix that mimics the native tissue more closely, thus directing differentiation 
along specific neural lineages.  
Results from Specific Aim 1 provide a thorough understanding of the matrix 
mechanical property range that can be achieved using collagen-based composite 
hydrogels of this type. This allows a comparison between the hydrogel properties and 
those of native spinal cord tissue. Additionally, the examination of gelation kinetics and 
component release reveals a clear image of the properties of the hydrogels in vitro. 
Results from Specific Aim 2 provide information to more clearly understand the 
cellular response to these hydrogels. These results elucidated which hydrogel 
composition can promote oligodendrocyte differentiation most effectively in vitro and 
revealed which hydrogel composition was most promising to translate to in vivo 
experimentation. A balance between mechanical properties and composition can direct 
differentiation toward oligodendrocytes.  
Results from Aim 3 reveal the functional effects of these hydrogels on 
regeneration after spinal cord injury. By examining the functional deficits and recovery, 
the effectiveness of promoting regeneration can be determined, providing feedback to 
sensory and motor functional recovery ability. Implementing the hydrogel best 
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mimicking native spinal cord tissue and promoting oligodendrocyte differentiation 
provides feedback on the translatability of the engineered transplant graft. 
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Chapter 2: Biomaterial Development 
SPECIFIC AIM 1: OPTIMIZE A NOVEL INJECTABLE HYDROGEL COMPRISED OF 
EXTRACELLULAR MATRIX COMPONENTS TO MIMIC MECHANICAL AND BIOCHEMICAL 
PROPERTIES OF NATIVE SPINAL CORD TISSUE. 
 The hypothesis of this work is that a hydrogel that mechanically and chemically 
mimics native neonatal spinal cord tissue should direct the differentiation of spinal 
progenitor cells toward oligodendrocytes 
Rationale for hydrogel composition 
The hydrogel composition was optimized from a collagen-based scaffold 
modulated with the addition of high molecular weight hyaluronic acid (HA) and laminin 
I. These components were specifically selected to affect the differentiation of neural 
progenitor cells (NPCs) to oligodendrocytes. Unlike more mature cell types, NPCs and 
oligodendrocyte progenitor cells express the surface integrin CD44 which binds HA, an 
otherwise non-cell adhesive component [12]. However, HA also prevents the maturation 
of oligodendrocytes [30] and was therefore not crosslinked into the hydrogel to prevent 
long term retention of this component in vitro and in vivo. Laminin is a cell adhesive 
component that is part of the basement membrane of the blood vessels in the developing 
CNS [6, 7, 143]. Developing NPCs migrate and mature in response to specific signals 
from these proteins, as evidenced by observations of oligodendrocytes maturation during 
the neonatal period of development [30, 144]. Neonatal tissue is soft (<1kPa) [28, 145] 
and has a high concentration of laminin I [6, 11, 138, 146] and high molecular weight HA 
[5, 13, 137, 147], signifying that these properties may be crucial to oligodendrocyte 
differentiation. 
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Collagen-based scaffolds were initially characterized by examining a range of 
collagen concentrations (1 mg/mL – 3 mg/mL) to assess compressive modulus. 1 mg/mL 
collagen hydrogels were extremely difficult to manipulate, and collagen hydrogels at 
higher concentrations (>2 mg/mL) had compressive moduli much higher than desired. 
Thus, 1.5 mg/mL collagen content was chosen to create hydrogels of similar compressive 
modulus to neural tissue. These findings align with similar results from previous studies 
[148]. Between-batch variability was assessed (n=6, repeated 3 times) to determine 
repeatability of hydrogel synthesis using a two-tailed F-test at a 90% confidence level. 
The batches did not differ significantly, therefore data from multiple batches can be 
confidently combined.  
Hydrogel synthesis 
Hydrogels were synthesized from rat tail collagen I (Corning, Corning, NY, 
CB354249), mouse laminin I (Trevigen, Gaithersburg, MD, 3446-005-01), and high 
molecular weight (1500 kDa) bacterial-synthesized hyaluronic acid (Sigma-Aldrich, St. 
Louis, MO, 53747). All hydrogels contained collagen to provide mechanical strength and 
stability. The collagen was diluted from the concentration provided by the manufacturer 
(10.08 mg/mL) to 3.75 mg/mL with 0.2% acetic acid, and collagen stock solution was 
then made by combining 4:1 (A:B), (A) 3.75 mg/mL collagen solution and (B) 5X 
DMEM in HEPES buffer. This solution was then vortexed for 10 seconds and stored on 
ice until use. Laminin was thawed slowly on ice or at 4°C and kept at the concentration of 
the stock solution provided by the manufacturer (6 mg/mL). Hyaluronic acid was 
dissolved at 15 mg/mL in deionized water overnight and stored at 4°C until use.  
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Hydrogels were fabricated by combining of the components at the appropriate 
concentrations (Table 2.1) with 1X PBS as a diluent to make four different hydrogel 
compositions: collagen (col), collagen HA laminin (Col HA Lam) collagen HA (Col 
HA), and collagen laminin (Col Lam). Final solutions were vortexed for 10 seconds and 
then centrifuged for 3 seconds to eliminate trapped air. All hydrogel synthesis work was 
performed on ice to prevent premature gelation. For cell culture experiments, 30 µL 
hydrogels were used and for mechanical characterization experiments, 120 µL hydrogels 
were molded in 8 mm diameter silicon molds (Grace Biolabs, Bend, OR). Hydrogels 
were placed in molds on parafilm for 40 minutes in a 37°C, 5% CO2 incubator for 
gelation. When hydrogels were removed from the incubator, they were immediately 














Collagen 1.5 - - 
Collagen HA 
Laminin 1.5 1.5 1.5 
Collagen HA 1.5 1.5 - 
Collagen 
Laminin 1.5  1.5 
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Methodology for mechanical characterization of hydrogels 
Mechanical characterization was performed on hydrogels prepared as described 
above; formed in 8 mm diameter by 2 mm deep silicone molds and allowed to equilibrate 
at room temperature in PBS for one hour prior to testing. 
Compressive modulus 
Bulk compressive moduli of hydrogels were determined using an Instron 
apparatus (Model 3345, Instron, Norwood, MA). Cylindrical samples were compressed at 
a rate of 0.1 mm/s to at least 60% strain. Moduli were calculated as the slope of the stress 
versus strain curve in the linear region within the first 20% of the strain [134] (see 
representative data, Fig. 2.1). The total sample size per group was n = 15, achieved by 
performing three batches with n=5 per batch. Hydrogels were excluded from the study if 
they were torn or damaged during or prior to transfer to the Instron. Data from this 
process were compiled to determine the average compressive modulus of each hydrogel 




Figure 2.1 Compressive modulus.  
(a) To assess the hydrogel response to compressive forces, hydrogels of ~8 mm diameter 
and ~2 mm height was exposed to compressive forces using an Instron. (b) Stress and 
strain were measured and plotted. From this, a linear region within the first 20% of 
compression was assessed to determine the slope of the line, which describes the 
compressive modulus. 
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Shear modulus  
Hydrogel response to shear stress was determined using an Anton Paar MCR302 
rheometer (Anton Paar, Graz, Austria). First, the hydrogels were subjected to an 
amplitude sweep from .01-100% strain at 6 radians/second to determine the linear 
viscoelastic range of the material (see representative data, Fig. 2.2). The median 
amplitude in that linear range, 5%, was chosen for subsequent frequency sweeps. 
Frequency sweeps from 0.1-100 radians/second were performed on all hydrogel 
compositions to determine the storage modulus of the hydrogel, which describes the 
elastic response of the material to shear stress. The total group size for each hydrogel 
composition was n = 6. Experimenters were blinded while acquiring data and during 
analysis. 
Statistics 
 Compressive moduli data were assessed using one-way ANOVA followed by a 
Bonferroni’s correction to determine significance (p<0.01) while minimizing type 1 error. 
Experimenters were blinded to hydrogel composition while acquiring the data and during 




Figure 2.2: Shear modulus.  
(a) To assess the response of hydrogels to shear stress, an amplitude sweep was 
performed on hydrogels of ~8 mm diameter and ~2 mm height using an Anton Paar 
rheometer. (b) The amplitude sweep was performed from 0.01%-100% strain to 
determine the linear viscoelastic range of strain, which in this case is from 1%-5.6%. A 
strain within this range was then chosen to perform the frequency sweep to assess the 
hydrogel shear moduli, which is comprised of two components, the storage modulus and 
the loss modulus. The storage modulus describes the elastic component of the hydrogel 
response whereas the loss modulus describes the viscous component of the response. 
 53 
Gelation kinetics 
Protein absorbance at 405 nm increases as crosslinking increases and hydrogel 
gelation occurs. This can be exploited to assess gelation kinetics by examining the 
increase and eventual plateau in absorbance during gelation. To assess time for gelation 
at 37°C, absorbance at 405 nm was assessed for 100 µL of pre-gel solution in a 96-well 
plate using a Synergy HT microplate reader (BioTek, Winooski, VT). Solutions were 
transferred from ice immediately to the pre-warmed (37°C) plate reader. Absorbance 
readings were recorded every 2 minutes for 50 minutes. A solution of DMEM+HEPES, 
diluted in PBS at the same concentration as in the hydrogels, was used as a negative 
control. Data was normalized to the initial readings following Equation 1, where A is the 
absorbance, A0 describes the initial absorbance, and Amax describes the maximum 
absorbance, or steady state value.  
 𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑  𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 =
A−A0
(Amax−A0)
    Eqn. 1 
 
Statistics  
 Normalized absorbance readings were compared between groups using a one-way 
ANOVA assessment followed by Bonferroni’s correction to assess between-group 
differences and minimize type 1 error with multiple comparisons. Experimenters were 
blinded to hydrogel composition during testing and analysis. 
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Hyaluronic acid release 
Hyaluronic acid is not crosslinked into the hydrogel and therefore is expected to 
diffuse away from the hydrogel structure in vitro and in vivo. To assess the rate of 
release, hyaluronic acid was conjugated to fluorescein isothiocyanate (FITC) (American 
Peptide, Sunnyvale, CA, 316846) using 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide 
(Sigma-Aldrich, St. Louis, MO, 25952) - N-hydroxysuccinimide (Sigma-Aldrich, St. 
Louis, MO, 130672) (EDC - NHS) chemistry. FITC was chosen based on its small size, 
especially in comparison to hyaluronic acid, so the conjugation should not alter diffusion 
kinetics of this component. Briefly, 0.08 mg/mL FITC, 0.75 mg/mL EDC, and 0.78 
mg/mL NHS was added to 10 mg/mL hyaluronic acid in deionized water and stirred on a 
stir plate for 4 hours at room temperature. This solution was then quickly transferred to a 
10,000 kDa dialysis cassette and dialyzed for 48 hours in an excess of distilled water, 
with the distilled water replaced every 12 hours. Following purification via dialysis, the 
solution was transferred to a 50 mL conical tube and lyophilized until dry (~48 hours). 
This solid was stored at -20°C until being used in place of unconjugated hyaluronic acid 
during hydrogel synthesis.  
30 µL Col HA Lam and Col HA hydrogels were placed in 120 µL of 37°C PBS in 
a 48 well plate, which was then placed in a humidified chamber in an oven at 37°C. 
Collagen hydrogels without HA (Col) were used to control for fluorescence associated 
with DMEM or uncrosslinked collagen release. The supernatant was removed every hour 
and stored for testing over the period of the experiment. A pilot experiment was 
performed over a 24 hour period at 3 hour intervals to determine a relevant experimental 
 55 
length. The experiment was performed every hour for 9 hours to quantify HA release. 
Fluorescence of the supernatant was examined at 480±20 nm excitation and 518±20 nm 
emission to identify FITC-conjugated hyaluronic acid using a Synergy HT microplate 
reader (BioTek, Winooski, VT). Fluorescence was measured from below the plate to 
minimize error associated with long measurement distances. A standard curve of FITC-
conjugated HA from 0 - 1 mg/mL in PBS was used to determine concentration upon 
release. Each composition of hydrogel containing hyaluronic acid was also dissociated in 
PBS and measured for total fluorescence to determine maximum HA content.  
Statistics  
All values are represented with mean ± standard deviation. 
Mechanical characterization of hydrogels results 
Assessing the mechanical properties of these hydrogels can provide insight to the 
cellular environment in culture and in vivo after transplantation. Recent literature 
suggests that mimicking native tissue is important to encourage directed differentiation 
(see Chapter 2), therefore mechanical characteristics of all hydrogel compositions used 
here were compared to compressive moduli of native neural tissue reported in literature. 
The ultimate goal of this project is to create an injectable hydrogel that promotes 
oligodendrocyte differentiation, which is expected to stimulate axonal regeneration in 
vivo. Mechanical properties of the hydrogels play a key role in this directed 
differentiation. NPC differentiation into oligodendrocytes has been shown to occur in soft 
materials when the compressive modulus is 0.1 - 1 kPa [28], and the storage modulus is 
 56 
near 100 Pa [28, 145]. In addition, general axonal regeneration is improved in materials 
with modulus from 0.4-5 kPa [28, 145]. 
Compressive moduli  
The compressive modulus of each hydrogel composition was measured to assess 
mechanical properties of the hydrogels. To mimic the native tissue, these materials 
should be relatively soft (0.1-1 kPa) [28, 134, 145, 149-151]. Neonatal brain tissue has 
been reported to have a compressive modulus between 0.1 and 2.6 kPa [28, 134]. The 
goal of this project is to develop a material to mimic native tissues, therefore, the 
materials for this project were optimized to have compressive moduli from 0.4 - 2 kPa by 
adjusting collagen concentration. 
Collagen alone (Col) hydrogels exhibited the highest modulus at 1.82 kPa, while 
the three-component hydrogels have the lowest modulus at 0.57 kPa (Fig. 2.3). These 
moduli are within range of developing central nervous system tissue, as indicated by the 
dashed line in Figure 2.3. It has been proposed that oligodendrocytes respond most 
favorably to compressive moduli 0.1 - 1 kPa [28], therefore, these hydrogels, particularly 




Figure 2.3 Compressive moduli of the four hydrogel compositions.  
The collagen alone hydrogel has the highest compressive modulus (~1800 Pa), whereas 
the hydrogels with other components added (either HA or laminin) have lower moduli 
(~1200 kPa). The hydrogel with three components has the lowest compressive modulus 
(~ 570 Pa). Interactions between components may cause a decrease in compressive 
modulus by interfering with crosslinking by binding to the crosslinking component (in 
this case collage) near the crosslink site or by introducing a higher hydrophilicity, thus 
preventing as tight of crosslinks in a hydrated environment. The compressive moduli of 
these hydrogels are softer than neonatal brain tissue compressive modulus (dashed line 
(1)) and in range of the expected moduli that will provide the most optimal stimulus for 
oligodendrocyte maturation (~0.4-1 kPa) (1). Note: n=15/group, *=p<0.05, **=p<0.01, 




Shear moduli were measured via rheology. To mimic native CNS ECM, these 
materials should be soft (20 - 100 Pa Storage modulus [28, 145]. The storage and loss 
moduli of the Col Lam hydrogel were highest (60.8 Pa, and 7.9 Pa for storage and loss 
moduli, respectively), compared to other hydrogels, whereas the Col HA hydrogel 
exhibited the lowest moduli (29.5 Pa and 5.5 Pa) (Fig. 2.4, Table 2.2). The Col HA Lam 
hydrogels exhibited moduli in the middle of the range achieved, with a storage modulus 
of 42.6 Pa and a loss modulus of 6.4 Pa. All of these components altered the shear moduli 
of a collagen base hydrogel, which exhibited storage and loss moduli of 33.9 Pa and 7.1 
Pa, respectively, in a predictive way based on the additional components of the hydrogel. 
Proteins respond in a more elastic manner to shear stress than glycosaminoglycans. 
Specifically, HA is a shear thinning glycosaminoglycan, so the response to shear stress 
may be more viscous rather than elastic in hydrogels with high HA content. All of the 
hydrogels tested followed the expected pattern of exhibiting a higher storage modulus 
than loss modulus, implying they exhibit material properties more similar to an elastic 
solid than a viscous liquid under shear stress.  
To mimic the native ECM environment most appropriately for the applications, 
the rate of cell growth and migration needs to be considered. Assessment of shear 
modulus at low frequencies is appropriate to determine the cellular environment because 
cells tend to grow and migrate slowly, so they would experience the hydrogel response to 
slow oscillatory shear forces, under which conditions, the storage modulus of brain tissue 
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was measured as near 100 Pa [145, 152, 153]. A frequency sweep allows assessment of 
material response over a range of behaviors, including cell growth and migration as well 
as frequencies associated with the systemic environment (6 rad/sec). The data reveal that 
the behavior of these hydrogels is similar to other soft hydrogels, with a sudden dip in the 






Figure 2.4: Shear moduli.  
Storage and loss moduli were measured for each hydrogel type. A representative plot of 
each hydrogel type is provided here. Collagen HA hydrogels have the lowest moduli, and 
Collagen Laminin hydrogels have the highest moduli. G’ below 200 Pa is in range of 
brain tissue (Levental) (Error bars are ± standard error of the mean. Note: n=6/group. 





Table 2.2: Storage and loss moduli ± standard error of the mean 
Hydrogel Type Storage Modulus (Pa, ± SEM) Loss Modulus (Pa, ± SEM) 
Col 33.9±0.991 7.1±0.156 
Col HA Lam 42.6±1.568 6.4±0.181 
Col HA 29.5±0.947 5.5±0.150 
Col Lam 60.8±0.765 7.9±0.145 
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Gelation kinetics results 
Because this project involves an injectable hydrogel, understanding gelation 
kinetics is important to evaluate the efficacy of this material for the proposed application. 
Gelation should occur slow enough to enable injection into the injured spinal cord 
without a sudden pressure increase or damage to the cord caused by the injection. 
However, in culture, the hydrogels are gelled prior to the addition of medium, therefore, 
rapid gelation is ideal so cells survive the encapsulation process without nutrients. The 
four hydrogel compositions exhibited different gelation times as determined from 
solution turbidity. Hydrogels containing laminin tended to gel slower (~26 minutes) than 
those without laminin (~18 minutes). HA did not appear to have an effect on gelation 
time. All hydrogels were completely gelled in 30 minutes at 37oC (Fig. 2.5). This 
timeframe is fast enough to allow cells to survive the gelation process yet slow enough to 
enable the experimenter to inject the hydrogel over 2 minutes during in vivo 
transplantation without concern of increased viscosity or internal pressure. Additional 
time is accounted for to align the needle with the injection site, therefore the ideal range 
is from 8-30 minutes for gelation. These date reveal some noise at the early timepoints 
indicating an interaction of the measurement with condensation on the plate. 
Additionally, when laminin is present, a decrease in the absorbance occurs prior to a 
sudden increase in absorbance, possibly due to the interaction of laminin and collagen 




Figure 2.5: Gelation kinetics.   
Gelation kinetics were assessed by examining the absorbance of 512 nm wavelength light 
through the hydrogel. As proteins crosslink, the absorbance through them at this 
wavelength increases. In a protein hydrogel, the measured values should equilibrate once 
the hydrogel reaches a gelled state. In all hydrogel types, the absorbance equilibrated 


































Hyaluronic acid release results 
 HA is not crosslinked into the hydrogels; therefore, it was hypothesized that the 
HA would diffuse from the hydrogel during in vitro culture and in vivo after 
transplantation. As predicted, complete HA release was observed by 9 hours in culture 
with PBS at 37 oC from each of the hydrogels with HA (Col HA and Col HA Lam) (Fig. 
2.6). It is important to release this component to allow oligodendrocytes to mature as 
neurites extend to allow the interaction between neurons and oligodendrocytes. 
Additionally, this component is shown to minimize scar formation in vivo; therefore, its 
short-term presence early after transplantation is beneficial.  
Specific Aim 1 Summary  
Four hydrogel types were examined for their compressive and shear moduli as 
well as gelation kinetics and HA release. To mimic native neural tissue, compressive and 
storage moduli were optimized to 0.4 - 2 kPa and 20 - 150 Pa, respectively. Additionally, 
HA was not crosslinked into the hydrogels and was shown to diffuse out of the hydrogels 
in 9 hours. The rapid release of this component ensures short term signaling to the cells in 






Figure 2.6. HA release from hydrogels.  
HA is not crosslinked into the hydrogel, therefore, it is expected to diffuse from the 
injected area when introduced to the in vitro and in vivo environments. To examine HA 
release from the hydrogels, HA was conjugated to FITC and hydrogel supernatant was 
collected every hour for 9 hours. Fluorescence of the supernatant was measured and 
normalized to fluorescence of supernatant from collagen alone gels in PBS. 
Concentrations of HA released to the supernatant was calculated based on a standard 
curve of concentration of HA. HA was released by 9 hours in each hydrogel type that 
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Chapter 3: In Vitro Cell Differentiation 
SPECIFIC AIM 2: EXAMINE THE DIFFERENTIATION OF NEURAL PROGENITOR CELLS 
TOWARD OLIGODENDROCYTES EMBEDDED IN DIFFERENT HYDROGEL COMPOSITIONS. 
Oligodendrocytes are beneficial to the regenerating central nervous system as they 
provide support to growing axons. By myelinating growing axons and remyelinating 
damaged axons, transplanted oligodendrocytes can be a powerful tool to assist in 
functional recovery. Oligodendrocytes differentiate in the neonatal period of 
development, which this biomaterial scaffold is designed to mimic. 
Cell isolation and neural progenitor cell culture 
All animal work was performed in accordance with the Institutional Animal Care 
and Use Committee at The University of Texas, Austin or the University of Florida. The 
spinal cords of E12 mice (C57BL6, Charles River) or E14-15 rats (Sprague-Dawley, 
Charles River) were isolated into Hank’s Buffered Salt Solution. Spinal cords were 
placed in DMEM F12 media with N2 supplement and a 
penicillin/ampicillin/streptomycin solution and dissociated mechanically by pipetting 
with a fire polished glass Pasteur pipette. About 1X106 cells were plated in a 10 cm tissue 
culture dish and cultured as free-floating cell aggregates or “neurospheres” in the same 
medium supplemented with 20 ng/mL basic fibroblast growth factor added every two 
days. After 7-14 days, the neurospheres were dissociated by pipetting with fire polished 
Pasteur pipettes. Cells were then split to 500,000 cells/plate and expanded for up to five 
passages. This culture technique is widely used to expand neural progenitor cells without 
inducing differentiation [154-156]. To verify that NPCs did not differentiate during 
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expansion, neurospheres were sectioned and stained for nestin, a marker for immature 
neural progenitor cells. Neurospheres exhibited minimal signs of differentiation (data not 
shown); however, for this study, only primary cells or cells from passages one or two 
were used. Hydrogels were seeded with cells at 100,000 cells/ 30 µL hydrogel, either 
immediately after isolation or after the first or second passage.  
Methodology for immunostaining and imaging for in vitro differentiation 
Cells encapsulated in hydrogels were cultured for five days, fixed in 4% 
paraformaldehyde for 20 minutes and prepared for immunostaining. Hydrogels were 
separated into two groups, (1) those to be stained for intracellular components and (2) 
those to be stained for membrane-bound components. Group 1 was prepared with a 
blocking buffer that contained 5% goat serum (Sigma-Aldrich, St. Louis, MO, G9023), 
and 0.5% Triton X-100 (Sigma-Aldrich, St. Louis, MO, 93443) in PBS. Group 2 was 
prepared with a blocking buffer that contained only 5% goat serum in PBS as membrane 
permeabilization by Triton X-100 was unnecessary and would disrupt membrane-bound 
protein localization and appearance. For each group, nonspecific binding was blocked in 
blocking buffer 1 hour at room temperature. In group 1, primary antibodies against β-III 
tubulin (to detect neurons, 1:500, mouse polyclonal Abcam, Cambridge, England, 
ab7751) and glial fibrillary acidic protein (GFAP) (to detect astrocytes, 1:500, rabbit 
polyclonal, Abcam, Cambridge, England, ab7260) were used and cell nuclei were 
counterstained with DAPI. In group 2, primary antibodies against NG2 (to detect 
oligodendrocytes, rabbit polyclonal, US Biological, Salem, MA, C5067) and O4 
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(Millipore, Darmstadt, Germany, MAB345) were used. In both groups, nuclei were 
counterstained with 4’,6-diamidino-2-phenylindole (DAPI). 
Fluorescence images were acquired using a Zeiss AxioImager Z2 (Zeiss, Jena, 
Germany) with a 20X objective. Image stacks were reconstructed into 3D projections 
using Zen software (Zeiss, Jena, Germany). Six images throughout each hydrogel were 
acquired on the AxioImager to assess cell differentiation. Each image was analyzed by 
manually counting the number of DAPI stained nuclei present using ImageJ software. 
Cells stained for each component were counted similarly; each image was overlayed with 
DAPI to minimize the possibility of double counting if cell membranes were not intact. 
Cells were only counted if the nucleus and the cell body were identified as colocalized. 
Two independent, blinded experimenters counted cells, and their scores were compared 
to minimize bias.  
Statistics  
A one-way ANOVA followed by a Bonferroni assessment was used to determine 
statistical significance (p<0.01) of cell type in different hydrogel compositions.  
Mouse cell culture results 
Mouse cell differentiation was examined to identify the hydrogel composition 
with the most efficient oligodendrocyte differentiation. All cell types (astrocytes, 
neurons, and oligodendrocytes) were present in all hydrogel compositions (Fig. 3.1), 
however, the differentiation profiles were different in each hydrogel composition. The 
three-component hydrogel (Col-HA-Lam) had the highest oligodendrocyte differentiation 
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efficiency with 59.1% oligodendrocyte differentiation. The hydrogel that produced the 
next highest percentage of oligodendrocytes was the collagen-laminin (Col Lam) and 
collagen-HA (Col HA) hydrogels with 27.2% and 26.7% NG2+ cell presence, 
respectively. Collagen hydrogels performed least efficiently for the 3D culture, with 1.5% 
NG2+ cell differentiation. Figure 3.2 shows the differentiation profiles in different 
hydrogel compositions, revealing the percentages of oligodendrocytes, astrocytes, and 
neurons. Cells were stained using anti-NG2 and anti-O4 antibodies to identify 
oligodendrocytes, anti-GFAP antibody to identify astrocytes, and anti-β-III tubulin 
antibody to identify neurons. Collagen alone (Col) hydrogels had the highest percentage 
of astrocyte differentiation, while collagen-HA (Col HA) hydrogels had the highest 
percentage of neurons present in the hydrogels. The three-component hydrogel increased 
differentiation of oligodendrocytes and neurons as compared to the collagen alone 
hydrogel. These results confirmed the three-component hydrogel’s applicability as a 




Figure 3.1: Mouse cells cultured in four hydrogel compositions examined with 
immunocytochemistry.  
Cells were stained with anti-GFAP (red, top) to identify astrocytes, anti-β-III 
tubulin (green, top) to identify neurons, and anti-NG2 (green, bottom), to identify 
oligodendrocytes. All cell types were present in each of the four hydrogel 






Figure 3.2: Mouse cell differentiation in hydrogels.  
E11.2-E14 mouse spinal progenitor cells were cultured in hydrogels for 5 days with 
DMEM F12 medium supplemented with 1% fetal bovine serum. No specific 
differentiation signals were provided. Oligodendrocytes (O4 and NG2) differentiated 
most optimally in Col HA Lam hydrogels, whereas Col gels promoted astrocyte 
differentiation. The cells were responding to the ECM components as well as the 
mechanical properties of the hydrogels. The phenotypic response of the cells is in 
response to the ECM components present and the mechanical properties of the hydrogel. 
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Rat cell culture results 
Rat cell differentiation was examined similarly to mouse cell differentiation. 
Similar trends were present in rat cell culture as were seen in mouse cell culture (Fig. 
3.3). Significantly higher values (p<0.05) were seen for oligodendrocyte differentiation in 
the three-component hydrogel for rat (66.75%) compared to mouse (59.1%) cells. Lower 
differentiation percentages of neurons were observed in Col HA hydrogels with rat cells 
(26.9%) compared to mouse (41.1%) cells (p<0.01). These differentiation profiles are 
promising to support the hypothesis that ECM composition and mechanical properties of 
the environment affect neural progenitor cell differentiation.  
Specific Aim 2 Summary 
The extracellular matrix components present, gelation kinetics, mechanical 
characteristics, and HA release all contribute to cellular differentiation in culture. Softer 
hydrogels, with compressive modulus of 0.57 kPa, storage modulus of 42.6 Pa, and loss 
modulus of 6.4 Pa optimally encourages differentiation of NPCs toward 
oligodendrocytes. These hydrogels provide cues to NPCs to direct their differentiation 
toward the three cell types present in the CNS; neurons, astrocytes, and oligodendrocytes. 
In an attempt to remyelinate axons that have been demyelinated after injury, hydrogels 
were optimized to direct the differentiation of cultured cells toward oligodendrocytes. 
Ultimately, these hydrogels were designed to act as a delivery vehicle for NPCs to the 
injury area after spinal cord injury and to provide cues to the cells after transplantation. 






Figure 3.3: Rat cell differentiation in hydrogels.  
E14-E15 rat spinal progenitor cells were cultured in hydrogels for 5 days in DMEM F12 
medium supplemented with 1% fetal bovine serum. No specific differentiation signals 
were provided. Similar to mouse cell cultures, oligodendrocytes (NG2) differentiated 
most efficiently in Col HA Lam hydrogels, whereas Col gels promoted astrocyte 
differentiation. The cells were responding to the ECM components as well as the 
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Chapter 4: In Vivo Assessment 
SPECIFIC AIM 3: IMPLEMENT AN INJECTABLE HYDROGEL-CELL SYSTEM INTO AN IN 
VIVO MODEL TO ASSESS FUNCTIONAL AND ANATOMICAL RECOVERY AFTER SCI. 
Spinal cord injury 
Model development.  
Contusion spinal cord injury was performed on female rats ages 8-10 weeks. This 
model is clinically relevant and an ideal hydrogel transplantation model: A cavity forms 
within the spinal cord after contusion injury providing a distinct injection location that is 
surrounded by spinal cord tissue, preventing diffusion of the pre-gel solution prior to 
gelation. 
Though this model has been previously developed and reported in literature, for 
the purpose of this project, specific verification and characterization was performed. 
Lesion volume analysis was assessed after application of a known contusion force. Five 
animals were euthanized one week post injury by trans-cardiac perfusion as described 
below. 12 µm cross sections were stained with standard cresyl violet staining. Analysis 
was performed every 120 µm to assess lesion size. The Cavalieri method [157] was used 
to estimate lesion volume to determine the appropriate hydrogel volume for 
transplantation. Briefly, using ImageJ, area of the lesion was determined on each stained 
section, and lesion volume was estimated using a rectangular Cavalieri’s method; this 
method expands the area of each section to a volume by multiplying the section area by 
the distance between sections (Fig. 4.1). One week after contusion spinal cord injury, the 
lesion volume was determined to be 0.62 ± 0.03 µL.   
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Figure 4.1: Cavalieri method.  
The Cavalieri method is a robust method to estimate the volume of unknown geometries. 
To assess this volume, sections are taken through a 3D object (a), in the case of this 
dissertation the lesion within the spinal cord, and the volume is projected through the 
next section. This leaves a volume assessment of consecutive solids with unchanging 
geometry throughout them. In this figure this is a series of consecutive cylinders (b), each 
of different diameter.  This volume assessment was found to be the most optimal for CNS 
volume estimation (cite). 
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Surgical methodology 
All animal work was performed in accordance with the Institutional Animal Care 
and Use Committee at The University of Texas, Austin or the University of Florida. 
Adult female rats (Sprague Dawley; Charles River), 8-10 weeks old, were anesthetized 
using isoflurane vapor (3% to induce and 2% for maintenance), and ophthalmic ointment 
was placed on the rats’ eyes to prevent drying during surgery. The surgical area from just 
below the scapula to between the ears was shaved and cleaned using chlorhexidine scrub 
and sterile saline to prepare the animals for surgery. A total of 24 animals were used for a 
two week experiment, and 40 animals were used for a 6 week experiment. Four groups 
(n=6) were included in the two week experiment, and five groups (n=8) were included in 
the six week experiment, as outlined in Table 4.1. A fifth group (laminectomy) provided 
a behavioral control without injury. The animals were subjected to surgery up to and 
including a laminectomy (removal of the dorsal portion of the vertebra) but did not 
receive any injury to the spinal cord.  
Anesthetized animals were transferred to the surgical table where they were kept 
under isoflurane vapor anesthesia for the duration of the surgery. A dorsal laminectomy 
was performed at the fourth cervical vertebra (C4) to expose the underlying spinal cord. 
Forceps on the Infinite Horizon Impactor (Precision Systems and Instrumentation, 
Virginia) were used to stabilize the vertebrae of C5 and C3. Animals to receive a 
contusion were placed under the Infinite Horizons Impactor fitted with the mouse 
impactor head (1.3 mm diameter) and an impact force of 150 kDynes was applied 
laterally on the left to induce a contusion injury. The wounds were then closed in layers 
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(muscle and overlying skin) using 5-0 absorbable vicryl sutures and 5-0 monofilament 
nylon sutures, respectively.  
Pain associated with surgery was managed using buprenorphine hydrochloride 
(0.03 mg/kg, Patterson Veterinary, Devens, MA, 07-850-2280) administered 
subcutaneously immediately prior to surgery and every 8-12 hours following surgery for 
48 hours. The antibiotic gentamicin sulfate (4-5 mg/kg, Patterson Veterinary, Devens, 
MA, 07-805-7791) was administered subcutaneously every 8-12 hours for 5 days starting 
one day prior to surgery and repeated if signs of infection were detected. Lactated 
Ringer’s solution (5 mL) was subcutaneously administered immediately following 
surgery and at later stages as animals showed signs of dehydration. This type of unilateral 
contusion spinal cord injury induced limited mobility with one forelimb and one hindlimb 
immediately following surgery. Animals regained hindlimb function to normal levels 
within two days after injury. All animals were examined to ensure their ability to access 
food and water readily during their recovery period of two weeks. All animals were 
monitored three times daily for five days after injury, and twice daily for the remainder of 
the two week recovery period. Animals were weighed daily; if they lost more than 10% 
of their pre-surgery body weight, dietary supplements such as NutriCal (Patterson 
Veterinary, Devens, MA, 07-836-0262) or DietGel Boost (Clear H2O, Portland, ME 72-
04-5022) were administered to supplement their diet. DietGel was administered for the 
first two days after injury and after as needed based on weight loss. This type of injury 
did not affect bladder function, however voluntary bladder voiding was assessed twice 





Table 4.1: In vivo experimentation groups. 
Experimental Group 
Group Size 
Two Week Six Week 
Hydrogel + Cells 6 8 
Hydrogel Alone 6 8 
Media + Cells 6 8 
Media Alone 6 8 
Laminectomy - 8 
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Cell and hydrogel transplantation methodology 
Prior to treatment transplantation, animals were separated into experimental 
groups based on behavioral scores acquired with the forelimb step-alternation test. One 
week post injury, animals were weighed and prepared for surgery as described above. 
The previous surgical site was reopened by removing sutures in the skin and gently 
pulling the skin apart. Muscle layers were separated similarly, and the spinal cord was re-
exposed to reveal the injury area. The tip of a 34 gauge needle on a NanoFil 
microinjection system (World Precision Instruments, Sarasota, FL) attached to a 
stereotactic stand was inserted into the spinal cord in the injury area approximately 50 
µm deep. A 0.6 µL solution of either Col HA Lam hydrogel solution or media with or 
without NPCs (passage 1) was slowly injected over 2 minutes into the cavity area. For the 
groups with cells, 20,000 cells were transplanted into the lesion cavity. The wounds were 
then closed in layers (muscle and overlying skin) using 5-0 absorbable vicryl sutures and 
5-0 monofilament nylon sutures, respectively.  
All pain management and post-operative care was repeated similar to after the 
initial spinal cord injury surgery with one exception immediately following 
transplantation surgery. Meloxicam (1 mg/kg, Patterson Veterinary, Devens, MA, 07-
890-7338) was also administered to animals for additional pain management.  
Behavioral assessment methodology 
Prior to surgery, a total of 3 weeks of handling and pre-testing was performed to 
acclimate the rats to being handled and to ensure that the animals exhibited normal 
behavior prior to surgery. Experimenters were blinded to animal group throughout 
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behavioral assessment. All behavioral tests were performed twice prior to surgery, 
immediately prior to transplantation, and once weekly following transplantation for up to 
6 weeks. Between-experimenter variation was minimized by maintaining the same 
experimenter for alternation, postural instability, and placing tests and utilizing two 
experimenters for the pasta, cylinder, and grooming tests. 
Postural instability test (PIT)  
To perform this test, animals had to be relaxed and comfortable in the 
experimenter’s hands; any struggle during a trial would disqualify that trial. Rats were 
held in an almost vertical position with only their forelimbs in contact with the tabletop, 
similar to a wheelbarrow type position, while their hindlimbs were allowed to hang free. 
This test was performed on P220 sandpaper to prevent slipping, bracing, or dragging of 
the forelimbs during testing. Lines were drawn on the sandpaper every 1 cm to facilitate 
scoring of distance during stepping. The experimenter first lined the rats’ noses up with 
the zero line as observed from above. Each rat was moved by the experimenter to shift 
the rats’ center of gravity forward over the forelimbs, stimulating the rat to take a step to 
regain its balance. The new position of the nose upon stepping was measured as the 
distance needed to trigger a step. Each forelimb was tested independently by lightly 
restraining the opposite forelimb during testing. Four successful trials on each forelimb 
were performed each testing period.  
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Forelimb step-alternation test 
This test was previously developed in collaboration with fellow researchers in Dr. 
Christine Schmidt’s lab and with Dr. Timothy Schallert in the Psychology and 
Neuroscience departments at The University of Texas [73, 105]. A modification of the 
PIT, this test assesses the animals’ ability to alternate forelimbs during a forward stepping 
motion. This test involves both forelimbs touching the tabletop initially in a comfortable 
stance, as determined by allowing the forelimbs to reach the table while the rat was held 
in an upright, wheelbarrow position. This allows determination of the alternation status of 
the animals; whether they are alternators (alternate the use of their forelimbs) or non-
alternators (fail to alternate use of their forelimbs) can yield information regarding lesion 
location and size. While the experimenter moved the rat forward over their forepaws, 
first, step paw preference was noted (left or right), and the rats were observed for their 
ability to alternate steps. Four successful trials were performed each testing period. 
Vibrissae-elicited forelimb placing test  
A vibrissae (whisker)-elicited forelimb placing test was used to determine 
forelimb placing asymmetry, modified as previously described in our manuscript from 
2012 [73]. The rats were held by their torsos, allowing their forelimbs and hindlimbs to 
hang free. The tail was also required to swing free: The score was not counted if the tail 
was used for support, nor if any of the limbs were used for support on any surface aside 
from the testing table. When instances of struggling stopped and muscle relaxation was 
achieved, the vibrissae on one side, and then the other, were stimulated by brushing them 
along a table top for ten trials on each side. A score of 0-4 was given based on the 
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targeted forelimb’s placing response. Intact animals typically place each forelimb on the 
tabletop and receive a score of 4 because of accuracy of placement. A score of 0 was 
given when no response was seen. A score of 1 was given when the animal’s limb 
showed movement but was insufficient to reach the table. A score of 2 was given if the 
animal’s forepaw touched the table but not the top of the table, and a score of 3 was given 
if the animal’s forepaw touched the tabletop with non-normal paw position. Average 
scores were calculated based on treatment group. Ten successful trials were measured 
each testing period. 
Cylinder paw use preference test 
The rats were rated live while being filmed in a transparent cylinder (20 cm 
diameter X 30 cm height) for 20 steps, but at most up to 2 minutes [73, 91]. Two 
experimenters independently scored each animal and compared results to minimize risk 
of bias. Three behaviors were scored during vertical exploration: (1) independent use of 
the left forelimb for weight bearing, (2) independent use of the right forelimb for weight 
bearing, and (3) use of both forelimbs simultaneously or rapidly alternating for weight 
bearing. In rare cases when experimenters were unable to distinguish which limbs were 
used, or whether simultaneously or independently used, the movement was not scored. 
Behaviors were scored as a percent use of each forelimb to total limb use, where half of 
the simultaneous use scores were allocated to each limb (Equation 4.1).  
𝑃𝑎𝑤  𝑢𝑠𝑒 =   100 ∗
!"#$%$"#$"&!!!  !"#$%&'()*$!
!"!#!
       Eqn. 4.1 
 83 
Pasta handling and eating 
Rats were observed while eating 4 cm strands of dry pasta [73, 102, 103]. Paw 
preference was noted during each pasta eating session. The test was administered at 
approximately the same time each day. Two weeks prior to injury, animals were given 
the same type of dry pasta to prepare them for testing. The rats were observed beginning 
the week prior to surgery and weekly thereafter. The animals were tested with three pasta 
pieces each testing period. Each paw was scored independently for use. The paw was 
considered in use if the paw was placed on the pasta in a supportive resting position or if 
the paw gripped the pasta for more than half of the time during eating. The average time 
to begin using the ipsilesional paw was calculated for each group for the 75% of animals 
that recovered this function. The animals were evenly distributed throughout the groups. 
4.1.1.1. Grooming test 
Animals were wetted using a soft gauze sponge with clean water starting at their 
noses up to the center of their backs. Animals were observed while grooming themselves 
in a familiar environment (a clear cylinder similar to the one used for the paw preference 
test) and scored based on their ability to groom different levels of their body using each 
paw on a scale of 0 - 5 (modified from [87]). A score of 0 indicated that the animal did 
not lick their paw; a score of 1 was given if the animal licked their paw and brought it to 
their nose. A score of 2 was given if the rat groomed between their eyes and their nose, a 
score of 3 was given if the animal groomed above their eyes but below their ears, a score 
of 4 was given if the animal groomed their ears, and a score of 5 was given if the animal 
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was able to groom behind their ears to the back of their neck. Grooming score 
descriptions are pictorially represented in Figure 4.2.   
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Figure 4.2: Grooming.  
Animals were observed while grooming and scored based on the level of function they 
expressed. Briefly, a score of 0 would imply that the animals did not lick their forepaw or 
touch it to any part of their face, a score of 1 describes the function of an animal that is 
able to lick their paw and touch their nose with that paw. A score of 2 implies that the 
animal can clean between their nose and eyes, whereas a score of 3 would describe the 
ability of an animal to groom above their eyes. An animal receiving a score of 4 should 
be able to clean its ears and a score of 5 describes an animal’s ability to clean behind its 




Behavioral data, with the exception of data obtained from the limb alternation and 
pasta eating tests, were analyzed by one-way ANOVA between groups (hydrogel + cells, 
media + cells, hydrogel alone, media alone, and laminectomy). Post-hoc analyses were 
performed when appropriate using the Bonferroni test (e.g. for PIT, vibrissae-elicited 
placing, cylinder preference test, and grooming test). All descriptive statistics are 
reported as mean ± standard error of the mean (SEM). The limb alternation test and pasta 
eating test present data in percentage of animals per group, thus statistical examination is 
limited. 
Tissue harvest  
At the end of the experimental periods, the animals were deeply anesthetized 
using an overdose of ketamine/xylazine. Trans-cardiac perfusion was performed using ice 
cold PBS (pH 7.4, ~200 mL) followed by cold 4% paraformaldehyde (~300 mL). The 
spinal cords were removed, post-fixed in 4% paraformaldehyde solution overnight at 4°C, 
and treated with 30% sucrose solution with 0.01% sodium azide prior to freezing. 
Sections were obtained using a cryostat (Leica, Wetzlar, Germany, CM1950) at 12 µm, 
thaw mounted onto gelatin-coated glass slides, and stored at -80°C.  
Methodology for immunostaining and imaging for in vivo experiment 
Tissue sections were dried on a slide warmer (Microscopes America, Cumming, 
GA, XL-2001) and a well was created on the slide using a hydrophobic pen. Sections 
were prepared for immunostaining in the same groups as the in vitro experiment (1) for 
cytoskeletal features and (2) for membrane features. Tissue sections were stained using 
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antibodies against (1) GFAP, b-III tubulin, nestin, bFGF receptor, and male-specific 
antigen UTY and (2) NG2, bFGF receptor, and UTY. UTY and bFGF receptor were used 
to identify transplanted cells. Additionally, some sections were stained for collagen I to 
identify the transplanted hydrogel. A description of each antibody and its targets can be 
found in Table 4.2. 
Some sections were stained using contrast staining methods including 
Hematoxylin and Eosin (H&E) staining or cresyl violet staining. For H&E staining, 
sections were dehydrated in xylene and ethanol, then rehydrated in water. Sections were 
then dipped in Harris Hematoxylin solution (Sigma Aldrich, St. Louis MO, HHS-16-
500ML) to stain nuclei, rinsed in water and placed in Scott’s solution until they turned 
blue. Following that treatment, sections were rinsed again in water and dipped in 1% 
Eosin solution (Electron Microscopy Sciences, Hatfield, PA, 62534-15) to stain the 
ECM, then dehydrated prior to being mounted with xylene-based mounting media and 
covered with a coverslip in xylene-based mounting media. For cresyl violet staining, 
sections were dehydrated in a series of ethanol washes from 70% to 100% ethanol, then 
rehydrated in the opposite order followed by a rinse in distilled water prior to incubation 
in 0.25% cresyl violet in acetate buffer for 2-7 minutes. Sections were then dehydrated 
again in ethanol and differentiated in 0.25% glacial acetic acid in ethanol followed by 
xylene rinses prior to coverslip placement using a xylene-based mounting media. H&E 
and cresyl violet staining were used to assess lesion extent. 
Cells in the cavity area were identified using the antibodies in Table 4.2 and 
examined to determine in vivo differentiation. Lesion extent was assessed by examination 
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of lesion volume comparison between ipsilesional and contralesional side of each section. 
Lesion extent was assessed by examining shrinkage of ipsilesional side compared to 
contralesional side. 
Statistics 
A two way ANOVA with Bonferroni correction was performed between groups 
to determine significant differences in lesion extent. Spearman’s rank correlation test was 
performed to correlate tissue loss to behavioral outcomes of tests that indicated 





Table 4.2: Antibodies used for in vitro and in vivo experiments. 
Antibody 
Name Antibody Specificity Identification 
In vitro/in 
vivo 
O4                - All stages of oligodendrocyte development y/n 
NG2 CSPG receptor All stages of oligodendrocyte development y/y 
GFAP Glial fibrillary acidic protein Reactive astrocytes y/y 
b-III tubulin Neuron- specific tubulin Neurons y/y 




growth factor Transplanted cells n/y 
Laminin Laminin I Extracellular matrix in hydrogels n/y 
Collagen  Collagen I Extracellular matrix in hydrogels n/y 
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Behavioral assessment results 
Postural instability test (PIT) 
This test reveals the animals’ ability to step in response to a shift in their center of 
gravity. Powerful data regarding compensation can also be acquired with this technique 
by testing the contralesional limb. The deficit was detected with this method, animals 
with injury on average had an increase in step length from ~11.4 cm / two steps to ~18 
cm/ two steps with the ipsilesional limb (Fig. 4.3a). This increase indicates that the 
functional deficit caused by the contusion injury affects the reflexive behavior to stabilize 
with a shift in center of gravity over the forelimbs. Similarly, a compensatory behavior 
was observed in the contralesional limb, with contused animals stepping on average ~8.9 
cm/ two steps compared to animals that received a laminectomy stepping ~11.4 cm/two 
steps (Fig. 4.3b). Unfortunately, no difference in functional recovery was observed 
between groups, nor was there an increase in functional ability throughout the experiment 
for any experimental group.  
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Figure 4.3: Postural instability test. 
This test assessed the animals’ reaction to a shift in center of gravity. (a) All groups 
presented a deficit in the function of their ipsilesional forelimb, however, there was no 
significant recovery in any group. (b) Assessment of compensation is also important 
when examining effects after a unilateral lesion. All groups expressed compensation on 
the contralesional limb, however, no change was observed throughout the 7 weeks of 
testing. 
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Forelimb step-alternation test 
Assessing animals’ ability to alternate stepping provides insight to the normal 
function of the animal under a forced motion task. A deficit was observed after injury and 
slight increase in functional ability in every group was observed greater than 60% of 
animals in all groups alternating steps by week 4 (Fig. 4.4), however, there was little 
difference observed between groups. The groups that received media with cells and the 
hydrogel alone had 75% of animals alternating (Fig. 4.4), however, this increase 




Figure 4.4: Forelimb step-alternation.  
This test examined the functional outcomes after unilateral spinal cord injury with respect 
to normal stepping during locomotion. No significant difference were seen between 




Vibrissae-elicited forelimb placing test 
Animals were examined for their ability to respond to a sensory input from their 
whiskers to stabilize their bodies on the tabletop. A deficit was observed one week after 
injury, and an increase in function was observed in the two groups with hydrogel 
transplants. By week 5, the group with a hydrogel + cells transplant performed 
significantly better than the media alone and media with cells groups (Fig. 4.5). This 
increase represents some animals gaining the ability to reach for the table, though not 
able to support themselves on the table. Gaining the functional ability to reach from a 





Figure 4.5: Vibrissae-elicited placing.  
This test examined the animals sensory-motor function unrelated to reflex by examining a 
motor task in response to a sensory stimulus unrelated to the direct spinal reflex path. 
Significant improvement was seen two weeks after treatment in groups receiving 
hydrogel transplantations compared to media groups. Four weeks after treatment, the 
hydrogel + cells group improved above hydrogel alone group, however, statistical 
difference was not found between the two groups. The improvement represents animals 
having complete paralysis of the ipsilesional limb and improving to having the ability to 
move their limb forward to touch the table.  
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Cylinder paw use preference test 
Animals were tested in free motion while exploring the walls of a vertical 
cylinder. This provides insight to relaxed, unprovoked behavior. A deficit was observed 
one week following injury and animals slowly regained some function over the following 
six weeks. Animals with a hydrogel + cells transplant performed significantly better by 
the sixth week after treatment than animals with a media alone transplant (Fig. 4.6). This 
implies that these animals are more likely to use their ipsilesional limb during normal 
motion. This follows from the placing data and supports the implication of increased 




Figure 4.6: Cylinder paw preference. 
Assessment of forelimb function with the cylinder paw preference test reveals an 
animal’s ability to use their paws in a normal motion task. All groups exhibited a deficit 
immediately after surgery and showed improvement over the weeks following treatment. 
However, the hydrogel + cells group improved significantly over the media alone group 
by six weeks after injury. Note: * p<0.05, **p<0.01 
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Pasta handling and eating 
Rats were observed eating pasta, providing insight to paw use in a motivated, 
though not forced situation. A deficit was observed one week post injury, with most 
animals exclusively using their contralesional limb to eat the pasta. All groups showed 
some improvement in paw usage following injury, however, this increase was not 




Figure 4.7: Pasta handling and eating test. 
Assessment of time to use the ipsilesional limb after injury reveals the speed of recovery 
for each experimental group. 75% of animals in all groups recovered function by week 7, 
however, the average time to recover function was different between groups, with the 
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Another motivated sensory motor test was used to assess the animals’ range of 
motion of their forelimbs. The grooming test provides motivation to the animals to use 
the full range of motion of their limbs. A deficit was observed one week post injury. 
Small differences between groups were observed, but no significant improvements were 
observed in any group (Fig. 4.8). 
Analysis of behavioral assessment results 
Few of the behavioral tests used exhibited significant differences between groups. 
These tests may not have been sensitive enough to detect the changes in functional 
recovery, and minimal functional recovery may have occurred over the timeframe of the 
experiment. This experiment was designed to examine recovery of function in response 
to remyelination and tissue sparing with treatment, however, a longer term experiment 




Figure 4.8: Grooming test. 
Forelimb assessment using the grooming test allows researchers to examine the animals’ 
response to a minimally stressful stimulus. Significant deficit was observed one week 
after injury, and all groups improved slightly over the following weeks. No differences 
were seen between groups. 
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Histological assessment results 
Lesion extent assessment.  
Lesion extent was assessed at two and six weeks post treatment. Significant 
differences in tissue loss based on lesion extent were observed between the hydrogel + 
cell transplantation group and the media alone transplantation group (Fig. 4.9) with the 
hydrogel + cell group losing 30.5% tissue whereas the media alone group tissue volume 
decreased by 51.7%. This may have been caused by the increased stability of the cavity 
or to the cellular response to the hydrogel transplants. Additionally, transplant groups 
with hydrogels were qualitatively assessed to have less collapse of the lesion area than 
media groups. 
Hydrogel identification 
The hydrogel was identified in the lesion area using collagen I and laminin I 
staining. The hydrogel appears to have integrated with the tissue well, with cells observed 
at the interface and in the lesion center in the hydrogel alone group as well as the 
hydrogel + cells group. This result implies interaction between the host tissue and the 
transplanted hydrogel. Additionally, little presence of the hydrogel 6 weeks after 




Figure 4.9: Lesion extent. 
Lesion extent was calculated by examining the difference in tissue volume between the 
ipsilesional and contralesional sides of the spinal cord at the epicenter of the lesion. 
Significantly more tissue was present at the epicenter in the hydrogel + cell 
transplantation group (p<0.01) compared to media alone groups. Spinal cord sections 
were stained with GFAP, β-III tubulin, and DAPI. Note, scale bar is 500 µm, **p=0.01. 
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Scar formation and tissue response 
Staining was performed to observe scar formation in the lesion area. Qualitative 
assessment of scarring revealed a more significant scar response in groups without 
hydrogel transplant, following the hypothesis that hyaluronic acid would interact with 
reactive astrocytes by providing signals to prevent further scarring. Examination of the 
morphology of the astrocytes at the lesion edge reveals a lower cellular density and a less 
organized scar in the hydrogel transplant groups (Fig. 4.10). 
Differentiation 
Transplanted cells were identified in the lesion using UTY and bFGF receptor 
staining. Additionally, differentiation of these cells and other cells in the lesion area was 
observed qualitatively. Some oligodendrocytes were present in the lesion cavity area of 
the hydrogel + cells group, and astrocytes were seen to have migrated throughout the 
lesion area in all groups, likely in response to infiltrating exogenous cells. In all groups, 
invading exogenous cells were present, implying a breach in the dura and making it 
impossible to assess differentiation of transplanted cells.  
Analysis of histological results 
 Histological assessment reveals a successful transplantation of hydrogels and cells 
and provides insight to the behavior of the transplanted cells. Lesion volume reduction is 
a promising outcome to this therapy, as tissue sparing provides hope that regeneration 




Figure 4.10: Scar formation. 
Scar formation was examined to determine the response of reactive astrocytes to hydrogel 
transplantation. A different morphology of the scar as well as decreased GFAP staining 
was seen in hydrogel treated groups (a) compared to media groups (b). Qualitative 
assessment determined that the astrocytes making up the scar were interacting with 




Specific Aim 3 Summary 
 Transplantation of hydrogels optimized to direct neural progenitor cell 
differentiation toward oligodendrocytes was shown to be a promising treatment after 
spinal cord injury. Over a short-term experiment, tissue sparing was observed. The 
regenerative capacity of these therapies will need to be determined with longer-term 
experimentation. The histological outcomes with hydrogel treatment are promising in 
their ability to spare tissue. A cell tracking technique that has been verified needs to be 
implemented to examine differentiation of transplanted cells in vivo. 
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Chapter 5: Discussion and Conclusion 
RESTATEMENT OF PROBLEM 
 Spinal cord injury is a debilitating injury that has insufficient therapeutic options 
to provide patients with functional recovery. Researchers are examining cell therapies to 
replace and enhance endogenous cell populations. When neural progenitor cells are 
transplanted, experiments are plagued by low cell survival and undirected differentiation. 
To attenuate the latter problem, biomaterials have been added to the transplantation 
protocol. However, many of these biomaterials do not play a specific role beyond 
supporting cell viability. The cells receive cues from the biomaterials used, but without 
control of the material’s mechanical and chemical properties of these materials, many 
researchers report undesirable differentiation of the transplanted cells. Research has 
recently shifted to modulation of the materials used for transplantation to direct this 
differentiation by conjugation with growth factors or the use of microparticles for 
sustained drug delivery. This dissertation presents a novel and exciting application of 
natural components to direct the differentiation of neural progenitor cells toward 
oligodendrocytes using cues present during development. Though the effects of 
mechanical properties on neural progenitor cell differentiation has been examined in 
culture [134], this technique was previously not applied to control in vivo differentiation 
of cells transplanted after spinal cord injury. 
 By controlling the mechanical properties of this hydrogel, cell differentiation can 
be directed toward oligodendrocytes, an important cell type to enhance axonal growth. 
Additionally, the composition of the hydrogel (collagen, hyaluronic acid, and laminin), 
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provides signals to the cells to induce migration and differentiation toward this cell type. 
Differentiation of spinal neural progenitor cells was examined in vitro and in vivo. 
Additionally, this study examined the effects of such a transplant on spinal cord tissue 
sparing after injury.  
6.1. Conclusion 
For this project, the intrinsic bioactivity of natural biomaterials was harnessed to 
direct cellular differentiation in vitro and in vivo in pursuit of the goal to encourage 
recovery after central nervous system trauma. However, the same material and concepts 
can be applied to regenerative engineering in many soft tissues. This biomaterial provides 
two key properties of a successful biomaterial (1) tunable mechanical properties and (2) 
native extracellular matrix cues. Additionally, the composition of this hydrogel is 
exclusively natural components, which allows cells to reorganize and rebuild the 
structure.  
SPECIFIC AIM 1: OPTIMIZE A NOVEL INJECTABLE HYDROGEL COMPRISED OF 
EXTRACELLULAR MATRIX COMPONENTS TO MIMIC MECHANICAL AND BIOCHEMICAL 
PROPERTIES OF NATIVE SPINAL CORD TISSUE. 
The research presented here aimed to design an engineered matrix for soft tissues 
using natural components, such as collagen, hyaluronic acid, and laminin. In Specific 
Aim 1, multiple hydrogel compositions were developed. These hydrogels were 
extensively characterized with respect to the mechanical properties, gelation kinetics, and 
hyaluronic acid diffusion. The mechanical properties were soft enough to present similar 
cues to cells as neonatal spinal cord tissue. The addition of each component affected the 
mechanical properties of the collagen base material. Independent control of mechanical 
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properties and extracellular matrix components may be important in biomaterial design to 
provide specific cues for each application. However, the mechanical properties here 
mimic the neonatal nervous tissue of interest sufficiently. 
Future  
More precise control of mechanical and extracellular matrix components of this 
biomaterial will make it translatable to multiple applications. Development of an 
injectable, thermally gelling material for transplantation with controlled mechanical 
properties not linked to composition will provide a material that will more easily assist 
researchers in distinguishing important characteristics for biomedical applications.  
SPECIFIC AIM 2: EXAMINE THE DIFFERENTIATION OF NEURAL PROGENITOR CELLS 
TOWARD OLIGODENDROCYTES EMBEDDED IN DIFFERENT HYDROGEL COMPOSITIONS. 
Cellular differentiation in the multi-component natural-based hydrogels used in 
this project was robust with the cell types examined making up nearly 100% of all cells. 
Three cell types were examined, astrocytes (identified with GFAP), neurons (identified 
with β-III tubulin), and oligodendrocytes (identified with O4 and NG2). All cell types 
were observed in all four hydrogel types, however, the percentage of oligodendrocytes 
present in the three-component hydrogels was greater than in the other hydrogel types. 
This differentiation was likely in response to the cues provided by the hydrogels.  
Recently, the response of progenitor cells to mechanical stiffness has become an 
exciting field for biomaterials engineers and stem cell scientists. In 2006, a seminal work 
out of the Discher group introduced the response of mesenchymal stem cells to differing 
mechanical properties and many researchers have continued to examine the responses of 
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progenitor and stem cells to mechanical cues [128]. Many researcher, however, examine 
cellular response to mechanical cues in two dimensional culture conditions. Three 
dimensional cell culture provides a more representative examination of cellular response 
in vivo and therefore provides a more physiologically relevant prediction of cell behavior 
after transplantation. 
However, mechanical properties of these hydrogels were modulated based on the 
composition of the hydrogel. This limited the ability to distinguish the importance of 
mechanical properties compared to the extracellular matrix component signals on cell 
behavior. It is important to distinguish the relevance of each signal type to the 
differentiation of neural progenitor cells.   
Future  
  Determining the cues that are most important for directing progenitor cell 
differentiation will provide researchers with better tools to control the environment of 
transplanted cells to encourage regeneration in the central nervous system. To achieve 
these goals, photocrosslinkable hyaluronic acid hydrogels used previously in the Schmidt 
lab [134] or poly(ethylene glycol) hydrogels with tunable mechanical properties [158] 
could be used to provide specific mechanical cues to cells in culture. With controlled 
mechanical properties, ECM components can be introduced to the hydrogels to provide 
specific cues to the differentiating cells. This approach would provide the means to 
determine the effects of each component whereas combinatorial effects of multiple 
chemical components could be studied without altering the mechanical properties 
significantly. 
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SPECIFIC AIM 3: IMPLEMENT AN INJECTABLE HYDROGEL-CELL SYSTEM INTO AN IN 
VIVO MODEL TO ASSESS FUNCTIONAL AND ANATOMICAL RECOVERY AFTER SCI. 
A unilateral cervical contusion model of spinal cord injury in the rat provided an 
optimal transplantation site and a large selection of behavioral assays to assess the deficit 
and recovery. This model represents a clinically relevant population and allows for 
examination of compensation and deficit. 
 The six behavioral tests selected examined different aspects of functional 
recovery. Many of them, however, were not sufficiently sensitive to reveal a difference 
between groups. Three of the six tests showed improvement after treatment with the 
optimized hydrogel and cells over the control by six weeks after transplantation.  
 Histological assessment two and six weeks after treatment provided insight to the 
cellular behavior in vivo. Results followed the hypothesis that tissue sparing would 
increase with hydrogel transplantation. Cell differentiation appears to follow the same 
trend as in vitro, supporting the hypothesis that the hydrogel signals would affect the 
cellular behavior in vivo and in vitro. The transplanted spinal progenitor cells used did 
not provide a sufficient means of tracking their location. Therefore, this experiment will 
need to be repeated with more identifiable cells.  
Future  
This experiment assessed early timepoint tissue sparing and lesion effects after 
transplantation of neural progenitor cells and hydrogels. However, regeneration is 
expected to start 8 weeks post transplantation. A more long-term experiment would 
reveal the effects of this therapy on functional regeneration. Additionally, the 
combination of a well-controlled hydrogel environment and finely tuned growth factor 
 112 
delivery; for example the delivery of platelet derived growth factor or ciliary 
neurotrophic factor [111] may provide a more optimal environment for oligodendrocyte 
maturation in vivo. 
CONCLUSION 
In conclusion, this research demonstrated a novel application of a 
biomaterial/progenitor cell construct to provide a possible path for developing future 
treatments of spinal cord injuries. Future work should be directed toward refinement of 
this or similar materials for more control of the tunability of each property. With this 
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